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INTRODUCTION
Tetanus is a threat to the life of every individual.
and some people have a muoh greater exposure to the dangers of
being infectedwith this disease than other people do.
The inspiration for the study of this subject came
fromwatching a 42 year oldwoman, who was the mother of four
small children, die from this disease.
The subject chosen is an extensive one, and muohwork
has been done in this field during the past fifteen yearswhioh
changes somewhat the concept and treatment of the disease.
In order to keep this paper from becoming unwieldy,
muoh of the textbook material - such as history and clinical
picture • is purposely either omitted or reduced to essential
features.

This step is necessary in order to place more

emphasis on the etiology, pathological physiology, current methods
of prophylaxis, treatment - including a recom.�ended form of
treatment, and an analysis of The University of Nebraska Hospital
oases with a discussion of the errors in the treatment of each
case.
This paper is written both for the author's own benefit
and for an analysis of current advancement in the subject.
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BRIEF SUMMARY OF THE SUBJECT

Definition:

Tetanus is a speoific disease entity oaused by

an infection with the baoillus Olostridium tetani and
characterized olinioally by a toxemia in which the central
nervous system is involved, producing spasms of the muscles.
(R. Spaeth• 1944)
Etiologl:

Tetanus is caused by the tetanus bacillus whose

natural mode of infection is through wounds • especially those
wounds contaminated with foreign material. (J. Brennemann • 1944)
The bacilli remain localized at the site of entry. and these
produce a toxin which causes the clinical picture •
.spwtoms:

There is usually an incubation period from one to

twenty-one days. though it may extend as long as 120 days, be•
fore the onset of the symptoms.
1. Prodro:mal symptoms are as follows:
1. Intermittent or persistent muscular spasm ot
various groups of muscles.
2. Generalized basal muscular rigidity.
3. Exaggerated reflex excitability characterized
by acute repeated toxic spasms.
4. Dysphagia.
5. Stiffness of neck and back with severe backache.
6. Stiffness of gait.
7. Colicky cramp-like abdominal pains.
8. Increased irritability and restlessness.

2. Clinical Symptoms are as follows:
1. Trismus within 48 hours after first symptom.
2. Risus sardonicus.
3. Generalized rigidity - maybe opisthotonos.
4. Tonic and asphyxial muscular spasms including
respiratory and laryngeal muscles.
5. Rigid abdomen.
3. Clinical course is as follows:
1. Decreased urination, incontinence, and constipation due to spasm of sphincter muscle.
2. Clear sensorium.
3. Little increase in temperature.
4. Slight increase in heart rate.

s.

Danger signs•
1. Rigid abdomen and chest.
2. Cessation of breathing.
3. Markedly increased heart rate, indicative of
exhaustion.

4. Laboratory findings are of very little value.
1. WBC - 12,000-14,000

80-90% segmented.

2. Cerebral spinal fluid - normal
pressure during muscle spasm..

- increased

3. Occasional smears or cultures of wound show
Clostridium tetani organisms.
5. Termination.
1. Acute death.
1. Asphyxial convulsion.
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2. Delayed death from exhaustion.
3. Death from pneumonia or sepsis.
2. If no death occurs 1. A gradual decrease in intensity and frequency
of superimposed convulsions.
2. A gradual decrease in generalized rigidity.
6. Diagnosis (R. Dandurand & R. Dussault - 1943)
l. History of a septic wound or or a surgical
wound with secondary infection.
2. Presence of painful muscular contractions with
paroxysmal spasms - beginning usually in the
muscles of mastication (causing the trismus and
sardonic grin) later extending to the back and
neck muscles (causing opisthotonos).
3. Slight polynucleosis.
4. Temperature

100-101° F.

5. Perfect lucidity.
6. Normal cerebrospinal fluid.
7. Electromyograms in diagnosis of obscure oases
of tetanus (A.S. Watkins - 1942).
Localized and atypical tetanus present difficulty in
making a diagnosis.

Eleotromyograms of summated action currents

of skeletal muscle are possible with the aid of an electrocardiograph (L. Gunther and J.E. Walker - 1943).

This is done by

the insertion of needle electrodes directly into the muscle mass.
Abnormal eleotromyographs are diagnostic of tetanus.
The electromyographic studies in oases of atypical
and localized tetanus are comparable in diagnostic significance

-4-

to the electrocardiographic tracings in oases of atypical and
silent cardiac infarctions.
7. Differential diagnosis (L.

c.

Cole - 1942).

1. Local affections of the mouth - usually painful.
Trismus is not painful.
1. Impacted wisdom tooth.
2, Tonsillitis.
3. Peritonsillar absces$.
4. Glands about the angle of the jaw.
2. Local tetanus.
l. Neuritis.
2. Arthritis.
3. Cephalic tetanus with cranial nerve palsy.
l. Bell's palsy.
2. Polio-encephalitis.
3. Meningitis.
4. Generalized meningitis or encephalitis.
(Note: for the last two conditions, do a lumbar
punoture.)
4. Primary abdominal rigidity.
l. Acute appendicitis.
2. Perforated ulcer - usually has more pain.
5. Reflex spasms distinguished from convulsions.
1. Hysteria.
2. Epilepsy.
3. Strychnine poisoning.
(Note: A detailed history is usually sufficient�
-5-

I

7. Complioations and sequels (R. Spaeth - 1944)
1. Pneumonia.
2. Compression fraotures of the vertebrae.
3. Respiratory obstruction.
4. Constipation.
5. Urinary retention - not due to musoular spasm.
Cystomyograms indicate a paralysis of the bladder
is due to an interference with the lower motor
neuron mechanism. (P. F. Eas'b.'nan and R. M. Nesbit •
1942) This interferenoe is due to the tetanus
toxin rather than to the antitoxin.
6. Cranial nerve paralysis.
7. Deoubitus ulcers.
8. Pathology (R. Spaeth - 1944)
The morbid anatomy has no real features to distinguish
it from other infectious diseases in general. The
postmortem findings represent secondary effects to
the condition of the body per se.
9. Prognosis.
Prognosis is very poor if the incubation period is
less than ten days, and it becomes increasingly
better in a ratio directly proportional with the
length of the incubation period provided that
oomplioations are kept at a minimum.

BACTERIOLOGY OF CLOSTRIDIUM TETANI
1. MorEhology:

(Jordan and Burrows - 1942)

A slender, motile (20-38 peritrichous flagella), gram
positive, sporulating rod with rounded ends.

The rod possesses

a characteristic drum-stick appearance when the spore is present.
Isolated colonies in deep dextrose agar have a wooly appearance.
Surface colonies are flat, rhizoid, or feathery, and usually
are over 1 mm. in diameter.

Colonies on blood agar cause

hemolysis.
2. Physiology:
The organism develops in plain or dextrose broth and
in brain, meat, agar. and gelatin from which air has been expelled by heating and excluded by some form of seal.

Growth is

greatly influenced by the presence of associated organisms.
Dextrose and other carbohydrates are not fermented by this
organism.
Sporulation is not inhibited by carbohydrates.

Spore

formation begins in about two days at 37°c - eight to ten days
at room temperature.

The spores are highly resistant.

See

Table Number I on the following page.
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Table Number I

Duration of Spore Resistance to Various Antiseptio Measurea

Type or Antiseptic Measure

5%

Duration of Resistance
10 hours

Carbolic Acid

0.001% Bichloride of Mercury
160°c

Dry Heat

120°c

Live Steam

3 hours

1 hour
30 minutes

The tetanus bacillus can be destroyed by ordinary
antiseptic measures.
3. !lE_es:
There are ten known types of this organism.

Types

I, II, and III are the most common in this country. (Jordan
and Burrows - 1942)

The toxin produced is immunological

identical; so the subdivision into the agglutinations types
has no apparent practical significance.
4. Toxin:
The toxin produced is of a dual nature:
1. Tetanospasm - which affects the nervous system.
2. Tetanolysin - a hemolysin, which has no apparent
significance in the sympton complex.
The toxin is filterable and can be separated from the
bacteria.

This substance is apparently protein in nature as it

-s-

I

is destroyed by proteolytic enzymes.

The toxin retains its

potency for a long time in a dry state and is an excellent
antigen as it gives rise to a high titre.
This toxin is one of the most potent poisons known.
If taken by mouth. this poison is harmless unless some lesion
like an ulcer is present. (M. Fernan-Numez - 1938)
There are qualitative difference between the toxins
produced by the different strains of Clostridium tetani in
that various amounts of the antitoxin are required to neutralize
the various toxins. (U. Friedemann and A. Hollander - 1943)
5. General Information:
The bacilli and the spores have a wide distribution
in the feces of all domestic animals.

There is a question

whether or not the organisms multiply outside of the animal
body. i.e., the intestinal tract.

These organisms are more

prevalent in certain areas. (J. Brennemann - 1944)
In a series of studies done on the distribution of
the tetanus bacillus during the World War I, the cultures of
193 soil samples taken from European battle zones show positive
cultures in 27%

or the oases. (J. Boyd and J. Maclennan - 1042)

In 57 out of 79 samples from the cultivated fields of England.
the samples show positive culture; but no organisms are present
in the samples taken from the "Wilds of Scotland tt.
The organism is present less frequently in the arid

desert soils of the Middle East. In 91 soil samples taken from
Cyrenaioa and the Egyptian Desert during World War II, only 8
samples yielded toxigenic cultures of Clostridium teta.ni.
The natural mode of entry into the body is through
wounds - especially those wounds contaminated with foreign
material.

The order

or frequency of infection by wounds is

first by punoture wounds; next by abrasions; and lastly, by
1

laoerations. The organism is probably introduced into the
body in the spore fonn.
According to some experimental

work

done, there are

many non-toxic producing strains of teta.nus bacilli which exist.
These strains exist in the soil, in dung, or even in a case of
teta.nus. (P. Fildes - 1927)

These strains are a variation from

the ideal tetanus bacillus.

There is no apparent return of

toxicity in any of these non-toxic strains.
There is, also, a great variation in the virulence
of the toxic-producing strains.
There is recorded some experimental work which shows
that humans carrying teta.nus bacilli in the intestines frequently
have blood serums which contain appreciable amounts of tetanus
antitoxin. (M. Fernan-Nunez - 1938)
In the sera of 30 individuals in whose stools no
tetanus bacilli-like organisms were found, with two exceptions.
no antitoxin could be demonstrated. (C. Tentroeok and J. Bauer 1923)
-10-

A small amount of the serum (.1 ce.) containing the
tetanus antitoxin neutralized 10+ M.L.D. of toxin. It may be
that acquired immunity is due to the baoilli's being present
in the gastro-intestinal tract; for it is known that the tetanus
bacilli will grown in this habitat.
Many of the individuals who have no tetanus bacilli
in the intestinal tract and whose serum is free of tetanus
antitoxin show agglutinations to the tetanus bacilli.

Probably

these people have been carriers in the past; and the agglutinens
have persisted longer than the antitoxin.

Under the circumstances

it seema likely that such individuals are potentially immune to
tetanus; but there is no demonstrable immunity due to the
environmental exposure. (J. Brennemann - 1944)
The fate of the tetanus bacillus in the tissues depends
on many factors.
1. Phagocytosis does not prevent germination of spores.
2. Positive oxygenation prevents spore gennina.tion.
3. Spore germination is aided by 1. Trauma..
2. Foreign bodies.
3. Tissue necrosis.
(Note) These foregoing factors ca.use a hindrance to
the blood supply which in turn gives poor aeration to the
tissues and permits increased germination of spores {P. Fildes - l:
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4. Seoondary infections, espec:ially other anaerobes.
Manytimes. the local response of the tetanus bacillus is in
significant, and visible changes are hard to see.

Suppuration

and gangrene are due to secondary organisms.
PHYSIOLOGY
The tetanus bacilli multiply at the site of innooulation
but these organisms remain localized and are never found in the
blood stream. (J. Brennemann - 1944)

These organisms liberate

a toxin which is very virulent. {Note) See discussion of toxin
under Bacteriology.
There are theories concerning the distribution of this
toxin.

The older theory is that this exotoxin diffuses through

the organism by means of the blood stream and by means of
ascending either along or through the peripheral nerve trunks
as far as the nerve centers. (Dandurand and Dussault - 1943)
This toxin, then, becomes fixed in the nerve cells causing an
increased irritability of the neuromuscular system.

The nerve

cells. especially the motor nerve cells, are hypersensitive to
the action of the toxin; and so the tetanus becomes fatal when
a certain amount of the toxin has been absorbed and fixed.
During the past ten years. a great deal of work has
been done on the physiological processes of tetanus which
alters somewhat the older concept of treatment and prophylaxis
of this disease.

The following material is a brief summary of
-12-

this new information.
The toxin is a water soluble substance of high
molecular weight.

When the incubation period for the onset

of the clinical picture caused by this toxin is less than
5 to 6 days; then. the mortality is about 90%.

If the incu

bation period is 10 days or more; then, the mortality is about
50%.
There is no route of the toxin to the central nervous
system by the nerve fibrils or neural lymphatics.
route is arterial. (J. Abel - 1934)

The only

This highly toxic blood

can penetrate every region of the body during the incubation
period without manifesting any evidence of poisonous nature.
Equal volumes of blood and lymph contain the same amount of
toxin.
A close association exists between the hemoglobin of
the blood and the tetanospasm of the toxin during the acute
stages of the disease as shown by experiments with guinea pigs.

(G. Shwartzman - 1940) Under experimental conditions. the
tetanospasm concentration of the blood i.s approximately directly
proportional to the hemoglobin oono�ntration.
The amount of toxin bound by the tissues is relatively
greater when it is introduced into the body in small emount
over a period of time. (J. Abel - 1934).
There is a rapid transfer of the excess toxin to
the blood-lymph system. According to experimental evidence.
-13-

any amount of toxin above the lethal dose, whether introduced
into the body by subcutaneous or intramuscular injections, is
so transferred. (J. Abel, E. Evans, and B. Hampil - 1936)
The excess toxin continues to accumulate here.

Small amounts

of the toxin can get into the very narrow tissue spaces by means
of the lymph system.
The toxin is never found in muscles; it does persist
for a short time in the spleen, liver, and £or a longer period
of time in the blood, lymph, lymph glands, and the peripheral
part of mixed nerves. (J. Abel - 1934)

Occasionally, the toxin

is found in the urine.
The toxin may exert some secondary actions. (J. Abel,
B. Hampil - 1936)

In some cases, the liver might rupture.

Metabolic alterations might occur so that there is a decreased
weight accompanied by a shock-like weakness and sometimes
emaciation even with a good food supply.

Should the toxin reach

a certain concentration in the cells of the non-reacting organs
capable of absorbing the poison, then, a derangement of function
might ooour in these organs.
The cause of the muscular rigidity as seen in local
and general tetanus is not an action of the toxin on special
centers but in its action on voluntary muscles. (J. Abel, B.
Hampil, A. Jonas, and

w.

Chalian - 1938)

The toxin exhibits a two-fold action; one• a central

effect, and the other. a peripheral effect. (A. M. Harvey - 1939)
(J. Abel, W. M. Firor, and w. Chalian - 1938)

The central effect, which is characterized by reflex motor con•
vulsions, is due to the poisoning of the motor nerve cells of
the spinal cord, medulla, and pons.

The peripheral effect,

recognized by the unremitting rigidity of voluntary muscles•
results from the fixation of the toxin upon the motor-end
plates.

This last observation is supported experimentally by

the knowledge that tetanus toxin is unable to produce rigidity
in denervated muscles; and, also, that muscles which have become
rigid as the result of the toxin relax at once providing the
nerve section is carried out soon enough. Furthermore, the
intraneural injection of a nerve with antitoxin - taking
caution against leakage into the surrounding tissues - is
unable to prevent the development of a local tetanus in the leg
produced by multiple intramuscular injections of toxin. At
the same time, the same type of tetanus is produced in the
opposite unprotected leg.
The determing factor in the peripheral effect of
the toxin is the integrity of the motor-end plates and not the
connection with the spinal cord. (A. M. Harvey - 1939)

Impulses

from the cord contribute to the local tetanus earlier in its
development.
In general, in tetanus involving muscles remote from
the site of the production of the t oxin, the persistent con
traction of the muscles - like those of the jaw - involves an
effect of the toxin on the motor endings of the muscles.
•15-

The rigidity of the muscles is not due wholly to a
state of contracture; for the muscle fibers are involved in
continuous, asynchronous, propagated contractions with different
and fluctuating rhythms.

After a period of tetanio stimulation,

the muscles in•local tetanus show a great enhancement of irregula.
activity; this being due to a decreased threshold of excitation
at the motor-end plates during a period of tetanus.
The transmission of the stimulation is mediated by
an impulse of a small ~harge of acetylcholine from the nerve
endings.

This substance acts as a direct stimulation of the

muscle fibers at the motor-end plates.

By means of a three-fold action, tetanus toxin produces a method for the persistent irregular activity of the
muscle fibers.
)Increased liberation of acetylcholine
Tetanus Toxin Causes ?(Increased synthesis. of acetylcholine
~Decreased concentration of cholinesterase
which destroys acetyloholine.
This persistent irregular activity of the muscle fibers is the
central feature of local tetanus.

By further experi~entation. it has been determined
that there must be a period of incubation between the inocculatioi
and the onset of symptoms and signs in both the peripheral and
central tetanus. (J. Abel. B. Hampil, A. Jones,

w.

Chalian - 1938

It is also noted that there is a complete absence of an upward
-16-
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passage of the toxin in the spinal cord - which finding helps
to refute the older theory.
In approaching the last phase of this discussion
of the physiological aspect of tetanus - the cause of death the experimental evidence suggests that the time of death is
predetermined by the faot that an absolute amount of toxin has
been fixed by the various organs of the body within the first
few hours after the requisite threshold concentration of toxin
has been reached or surpassed in the tissue spaces. (J. Abel,
E. Evans, and B. Ha.mpil - 1936)
There is no blood-brain barrier for the toxin that
prevents the poison from gaining access to the susceptible
neurons of the neural a.xis.

Instead, the responsive parts of

the central nervous system begin to absorb and irretrievably
fix the toxin from the moment it reaches the nervous system.
via the blood streams.

The central nervous system. aots exactly

as do the other organs of the blood which have an affinity
for the tetanus toxin.
The toxin is fixed in a non-recoverable and non
assayable form in a relatively short time by all organs of the
body that have an affinity for the poison including the motor
neurons of the central nervous system and the end-plates of
the voluntary muscles. (J. Abel, B. Ba.mpil, A. Jones, and
Chalian - 1938)
Direct penetration of the nerve oells and their
-17-

w.

stimulation by the tetanus toxin is not essential for the pro•
duction of generalized tetanus.

(P. N. Kartashov - 1939)

The

process of tetanus develops from the time of contact of the
toxin with the peripheral receptors.

Further progress of the

disease, its generalization, and even its residuals occur
without participation of the specific agent causing the condition
tetanus toxin.
From the moment after the activity of me irritant,
certain nerve mechanisms acquire a dominant importance in
determining the course of the succeeding reactions after the
new irritant has affected the nerve nests.
It is not impossible for the onset of tetanus to
occur under the influence of a non-specific irritant at some
later date after the infection when no traces of the tetanus
toxin are present in the body
The metabolic changes consequent to the constant
musoular spasms are not the principle factor in causing death.
(W. M. Firor, A. Lamont, and B. H. Schumaker - 1940)

In the

absence of muscle spasm, life is prolonged to some extent; but
death ensues fairly promptly.

The prolongation is probably due

to the impaired oiroulation of the spinal oord and not due to
the abolishion of the convulsive movements.

Experimentally•

there are no blood changes in dying dogs which could account
for the death.
The lethal agent doe s not pass up me spinal cord

in the oerebrospinal fluid or within the substance of the oord
itself.
Toxin in the cerebrospinal fluid has the same
lethality and action as when it is injected into the blood
stream.

(w.

M. Firor, H. B. Schumaker, and A. Lamont - 1940)

The toxin is not multiplied and retained in the
lumbar cord; therefore, the lethal agent must reach some vital
center by way of the blood-lymphatic system. (W. M. Firor, H.
B. Schumaker, and A. Lamont - 1940)
If the toxin was multiplied and absorbed by the
blood stream in amounts sufficient to caU8e death, there would
be present such signs of general tetanus as already described.
These signs do not appear in experimental animals dying from
the injection of the toxin into the spinal cord.
Death still occurs even though the blood and lymph
contain large amounts of antitetanio serum through the entire
course of the experiments.

Obviously, if the toxin was multi

plied and absorbed by the blood stream. it would be neutralized
by the antitoxin.
On the basis of the foregoing informa.tioo, the follow•
ing theory has been advocated.
1. The toxin in the spinal cord is altered into a
new lethal agent that is absorbed by the blood stream and is
carried to some vital center where it has its lethal effect.
2. This new toKin is not neutralized by the tetanus
-19-

antitoxin.
Aooordingly, the administration of antitoxin is in
effective once the lethal dose has been fixed and the symptoms
of central nervous system tetanus are present; but since in
humans

there is no way of telling whether a· lethal dose has

been fixed, the antitoxin should be given and continued to be
used in local or general tetanus in the hopes that a lethal
dose has not yet been fixed by the body tissues.
It is suggested that the respiratory center is the
vital center on which the new lethal agent aots and that this
new agent's action may be enhanced by respiratory depressants.
For example - in experiments with animals that have the symptoms
of

tetanus present, the injection of the usually safe dose of

nembutal will kill the animal in a short time.
In animals in which the toxin is given intravenously,
and convulsions result, the administration of enough avertin or
nembutal to stop these convulsions will shorten the animal•s
life.

The injection of toxin into the medulla oblongata.
of dogs causes death to occur two times as fast, and much
smaller doses of the toxin are needed; therefore, care should
be exercised in the use of respiratory depressants for the
treatment of tetanus.
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IW.ITJNITY
An attack of clinical tetanus does not stimulate
the production of any antitoxin. (J. V. Cooke and F. G. Jones 1943)

Because of this situation. there is no natural immunity

to the disease as such - though some investigators claim that
certain people have circulating antitoxin titres produced
possibly by having the tetanus organisms inhabit the gastro•
intestinal tract.

(See the discussion of the bacteriology of

the disease.)
In oases of tetanus, the amount of tetanus toxin
absorbed is so small that it is insufficient to produce a
primary stimulation or sensitization to produce an active
immunity to the disease.
As indicated in the introductory remarks concerning
the disease in general and in the discussion of the bacteriology
of this disease, there is a definite need for prophylactic
measures against tetanus.
At the present time, there are two methods for pro
ducing this needed prophylaxis.
1. By the use of antitoxin which produces a temporary
type of immunity on a passive basis.
2. By the use of toxoid which produces a more permanent
type of immunity on an active basis.
Tetanus antitoxin has been in use for a considerable

number of years.

The accepted indication for the use of anti-

toxin is, merely, any injury in which there is the slightest
danger that the tetanus bacilli might be carried into the
wound.
As a general rule, if 1,500-5,000 units of tetanus

antitoxin are injected subcutaneously within a few hours of
injury, tetanus will fail to develop. (J. K. Calvin - 1941)
In severe injuries of the crushing type or compound fractures,
or after a considerable lapse of time from the injury, doses
from 5,000 to 10,000 units are indicated.

In these latter

types of injuries, a combination of gas bacillus antitoxin
with the tetanus antitoxin is a good and safe policy to follow.
From the work done on the use of toxoid, it has
been established that a titre of 0.10 units of antitoxin
per cubic centimeter of blood gives ample protection against
the tetanus toxin. (L. Unger - 1942)
The following tables show the duration of the
passive immunity as rendered by the injection of antitoxin.

(J. V. Cooke and F. G. Jones - 1943)
Table Number II

Duration of Large Doses of Antitoxin - 100,000 Units+ in Eight
Injected Children

r

Titre Level

Duration after Injection

Initial

Fell quickly

1.0 units

3-4 weeks

O.l units

6-10 weeks

0.01 units

8-11 weeks
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Table Number III
Duration of Moderate Doses of Antitoxin - 10,.000 Units in Fourteen of Twenty-One Injected Children
Titre
0.1 uni ts
0.01 units

Level

Dur~tion after Injection
4-6 weeks

-

6-10 treeks

The use of 1,500-4,500 units of antitoxin rarely
gives an adequate protection of 0.1 units in the blood titre.
There is a rapid fall after seven days to zero at three to four
weeks. (L.A. Yeazell and

w. c.

Deamer - 1943)

The average

incubation period is seven to fourteen days.
The fact that the prophylactic use of tetanus antitoxin is warranted in non-immunized individuals is borne out
by observations made during World War II.

The following in-

structions were issued in England for the treatment of air raid
casualties. (J. Boyd and J. Maclennan - 1542)
1. Surgery to remove any foreign body or necrotic
tissue.
2. Three thousand units tetanus antitoxin prophylactically to slight wounds.
3. Six thousand to nine thousand units tetanus antitoxin prophylactically to severe wounds.
During a two-year period in one London sector, there
were seven deaths due to tetanus,. six of these individuals
had received prophylactic doses of antitoxin.
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Table Number IV
Tetanus in World War I
(L. A. Yeazell and W. C. Deamer - 1943)
Military Force

-

British Expeditionary
l
Germans - all fronts
1914

Incidence of Tetanus Percentage of
Mortalit
er 100 wounded men

---

United States

l

0

3.8

75.0

0.2

ll.l

There are recorded in the literature many routes of
administration of antitetanio serum. (S. Ciancarelli - 1940)
1. Intra.cerebral)
2. Intra.carotid )

Not of much proven value.

3. Intravenous )
4. Intramuscular)
5. Subcutaneous )

Widely used.
Large amounts are tolerated.

6. Intra.spinal
) Good results obtained by some men.
7. Intracisternal) Use condemned by others.
In experiments on dogs, it is shown that t he intra
cisternal injection of antitoxin yielded better results on dogs
suffering from moderately severe tetanus than did the intravenous
injection of the antitoxin. (W. M. Firor - 1940)

In animals

with severe tetanus, the resu 1ts obtained by the use of the
various routes of injection showed very little varianoe.

The

intraoisternal injections showed better results than did the
lumbar injections.

The results may be due to the production of

a non-specific inflammation.
This method of direct injection into the cerebrospinal

canal has been advocated by other workers as well (R. Spaeth
1941).

There are objections to this route of administrati�
in that it produoes an increased intensity of the neuromusoul
irritability in tetam.s. (R. Spaeth ... 1941)
As for the accessibility of th e antitoxin to the
central nervous system. there is no blood-brain barrier for
the a ntitoxin; and neither is there any barrier for the tetar
toxin. (J. Abel. E. Evans, and B. Ha:mpil - 1936)

The cerebrs

capillaries of both the rabbit and the guinea pig are equallJ
permeable to antibodies. (U. Friedmann, B. Zuger, A. Hollandt
1939).

These capillaries are impermeable to substances carr�

a negative charge but are permeable to substances carrying a
positive charge; therefore, the permeability of the capillarj
depends on the amphoteric nature of the antibody.
The exohange of antibodies between blood and
tissues is extremely rapid •

.Antitoxin injected into a pregni

woman passes through the placenta and can be detected in the
cord blood of the newborn. (M. Fernam-Nunez - 1938)
In view of what has been presented previously as r,
the physiology ot

tetanus, the reports in the literature of ·

last few years contain some experiments that might alter the
role played by the a ntitoxin serum.
The time of death 1s fixed by that fraction of the
':oxin which has been fixed by the specifically reacting orgaJ
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of the body in the first few hours during which exposure to the
requisite threshold oonoentration of the poison occurred. (J.
Abel, B. Hampil, A. Jonas, and

w.

Chalian • 1938)

This toxin

begins to be fixed in an irreversible manner from the moment
it begins to reaoh, via the blood stream, the motor neurons
of the central nervous system and the end-plates of the voluntary
musoles.

The antitoxin neutralizes only that toxin whioh has

not been irreversibly fixed by the motor neurons and the end
plates.
Further experiments show that the antitoxin is
powerless to reduce or abolish the existing symptoms of tetanus
in humans whose tissues have fixed one or more lethal d oses of
the toxin before the serum was used. (J. Abel and W. Chalian 1938)
This antitoxin fails if its injection is delayed
until the incubation period merges with the onset of symptoms.
In the oases of humans, however• the knowledge of
whether a full lethal dose of toxin or one that allows recovery
has been fixed is unknown; therefore. every type of a prior looal
tetanus in whioh an intense vasodilatation occurs with edema
of the skin, muscles, bursae, and joint tissues.

As the serum

sickness is primarily a disorder of blood vessels, the
nutrition of the tissues � espeoialy of the nervous system .
is impaired.

This reaction causes a temporary interference

in the activity of the nerve oells and fibers.

Occasionally

this interference is permanent and oell deuth with parenohymal
necrosis follows.

Edema of the perineural sheaths gives the

neural syndromes - either radioular or spinal.
The following reports emphasize the oomplioations of
serum sickness - especially those of the nervous system.
1. Thirty-four or forty-nine cases or nerve involvement followed use of tetanus antitoxin. (H. M. Taylor - 1942)
1. Paralysis of the braohial plexus • most common.
2, Optic nerve paralysis • next most common.
3. Cranial nerve VIII involvement resulting in
permanent paralysis - fairly common.
2. Case of paralysis of recurrent laryngeal nerve temporary. (K. Sohauweoker - 1933)
3. Five oases of brachial plexus involvement with
permanent residuals. (H. Sprookhoff and I. A..�sorge - 1938)
4. Report on 18 oases found in German literature plus
a oase of 5-6 oervioal nerve involvement.( G. Weber - 1939)
5. Report on a case of anaphylaotio shook which re
sulted in hemoooncentration. (H. Blotner - 1942)
6. Report on a death which followed a prophylactic
injection. (A. Gommelgaard)
The autopsy showed the following findings.
1. Capillary hyperemia of the organs and edema.
2. Perivasoular hemorrhages in the brain-especially
in the medulla oblongata.

3. Small hemorrhages in the kidneys.
4. Eoohymosis in the myocardium.
There was no manifestation of shook until 15 minute�
before death occurred.

There was no history of previous ana

phylaotio reactions and no history of previous injections of
serum.

The perivasoular hemorrhages in the brain were considi

the cause of death.
7. Report of University of Nebraska Hospital Cases
Four out of six oases treated with multiple doses of antiserUl
resulted in some form of serum reaction. (2 cases of urtioari,
l case of serum sickness, and 1 case of permanent motor and
sensory paralysis from level of xyphoid process down.) Note:
See case reports at end of paper.
In an effort to prevent antitoxin reaction, the
oral use of 20 units of histaminase every four hours until th
patient was symptom free for both generalized and localized
serum reactions failed to show any effect on either the durat
or the intensity of the symptoms. (S. A. Eger and J. E. Stone
1944)
As is seen from the foregoing discussion, the use
or tetanus antitoxin is a serious matter; and it warrants oar
and discretion.
In order to produce a more lasting immunity and to
lessen the dangers of serum reactions, a method of active
immunization has been developed during the past decade.

There are certain advantages connected with this type
of immunization. (R. A. Cooke, S. Hampton, W. B. Sherman, and
A. Stull - 1940)
1. The serum antitoxin titre is raised to a level
higher than that level obtained with a prophylactic dose of
antitoxin.
2. The titre obtained by active immunization is more
lasting.
3. The titre is rapidly elevated by an injection of
tetanus toxoid in an emergency.
4. This method of prophylaxis avoids the real dangers
of reactions or sensitizations incident to serum administration.
This type of immunization is very useful where the
threat of tetanus is ever present due to accidents.
Table Number V
Tetanus in Industrial Accidents
(P._ _g_am_p_i_~l!~ - 1943)
Vital Statistics from the United States Census Bureau
Year

Ntt!llber of Deaths from Tetanus

1933

1253

1934

1226

1935

1057

1936

1088

1937

930

1938

637
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There are many professions and states in life that
have a particular exposure to tetanus. (M. Fernan-1Junez - 1938)
1. Pregnant women

8. Farmers and dairymen

2. Childrer:t

9. Poultry men

3. Athletes

10. Cattlemen

4. Soldiers

11. Cement workers

5. Sailors

12. Truck drivers

6. Physicians

13. Policemen

7. Bacteriologists

14. Industrial workers

Active immunization is a safe, practical, and
desirable procedure and should be employed routinely in
children, farmers, and all others whose vocations or avocations
make them liable for tetanus infection. (J. H. Lyons - 1944)
Basic immunity is the goal desired in active im
munization.

This basic immunity is a measure of the ability

of the tissue to re�ot with the production of antitoxin. (J.
J. Miller and J. B. Humber - 1943)
The tetanus toxoid is prepared from tetanus toxin
produced in broth. The M.L.D. doses of tetanus toxin do not
parallel the antigenicity of the tetanal toxoids prepared there
from. (W. L. Koerber - 1943)

The combining power values (L+ or

of tetanal toxins cannot always be used for evaluation of the
antigenicity of the corresponding toxoids; however, for certain
toxins compared under definite conditions, a parallelism exists.
The most reliable test for determing the antigenicity of the
-30-
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tetanus toxoid is by means of an antigenicity test or guhea
pigs or mioe.
The toxin, now being used as a standard for t he
production of the toxoid is produced in a hog stomach autolysate plus veal infusion broth so that the toxin conta:hs
100,000 M.L.D. per milleliter. (D. T. Fraser, D. L. MaoLean,
H. C. Plummer, and F.

o.

Wishart - 1943)

There are various types of toxoids manufactured.
The alum precipitated toxoid appears to be superior to fluid
toxoid. (J. J. Miller and J. B. Humber - 1943)

In turn,

aluminum hydroxide seems superior to alum in the preparation of
tetanus t oxoid.
1944)

(J. J. Miller, J. B. Humber, a�d J. O. Dowrie -

More stable levels are produced with very little tendency

to decrease.
There is some dispute as to what is the best method
of producing active immunization.

The following regime is

used by the United States Army. (Major A. P. Long - 1943)
1. The original toxin is produced in Witte or Berna
peptone broth and contains 10,000 M.L.D. per milleliter.
2. A plain fluid toxoid is used.
3. One (1) milleliter of fluid toxoic is given every
three weeks f'or three (3) injections.
4. One (1) milleliter of toxoid is given one year
after the completion of the basic immunization.

5. One (1) milleliter of toxoid is given at the time

of departure for the com.hat zone unless the previous "booster
dosen was given within the past six months.
6. One (1) milleliter of toxoid is given at the
time of injury.
Antitoxin production begins on about the fifth day,
and the peak is reached on the tenth to fourteenth days. (J.
Boyd and J. Maclennan - 1942)

There are certain conditions

which influence the process of active irr.anunization.
1. There is found occasionally a subject who does not
react to the innoculation with toxoid.
2. For a week, the circulating antitoxin may be small
in quantity.
3. Antitoxin production may be less active in a bad
ly wounded and shocked subject.
In guinea pigs immunized with two doses of alum
precipitated toxoid and infected with tetanus spores, there is
no increase in the antitoxin titre e,rident for eight to ten
days. (B. Zuger, C. Greenwald, and H. Gerber - 1942)

If, how

ever, at the time of infection with the spores an additional
dose of toxoid is given, the antitoxin titre increases rapidly
within five days.
There is some discussion at the present time as to
whether two or three injections of toxoid

are

necessary to pro

duce an adequate basic immunization.
In a plan proposed to eliminate the low levels of
-32-

antitoxin titre obtained one year after basic immunization, it
is suggested that instead of the intervals between the primary
injections of one cubic centimeter of toxoid being six weeks
apart this interval should be two to three months apart.

There

is a large increase in the antitoxin titre following a third
dose

or to.xoid whioh is given seven to nine months later. (D.

M. Marvell and H. J. Parish - 1940).
Two injections 0£ one-half cubic centimeter of alum
precipitated toxoid injected subcutaneously at intervals of
two to three months will protect almost all individuals. (L.
Unger - 1942) After the two injections, the amount of tetanus
antitoxin increases to over 0.10 units per oubio centimeter.
This titre gives ample protection.
If this titre is not reinforced by a "booster dose�
of toxoid, it will steadily decrease from its peak. A stimulating
dose of toxoid at the time of injury will rapidly restore the
titre to a safe level.
Another investigator shows that after the administration
of a third dose of tetanus toxoid there is an increase in the
conoentra�ion of the antitoxin in the blood. (D.

c.

Evans • 1943)

For at least eighteen months, a higher concentration of antitoxin
remains than that antitoxin titre resulting from two doses of
toxoid.
Some investigators on a series of children contrasting
the two types of basio immunizing procedures show remarkable
-53-

results. (J. J. Miller and J.B. Humber - 1943)

One series of

children received two injections of one oubio centimeter of
toxoid at eight-week intervals.

The other series of children

received two injections like the first group plus another in•
jection at sixteen weeks.

-

Table Number VI
Number of Children with Antitoxin Titres Below 0.10 u/co When
Tested 9-15 Months After Completion of Immunization
Three Injections

Two Inj eo ti on s

4 in series of 42

15 in series of 54
27.7%

9.2'.%

(Note:

The difference in the percentages is 18.2% ± 7.2%)

The foregoing information is important as it shows
that complete protection is rendered for a given period of time
even though reinjection is unintentionally omitted after trauma
has occurred - in an instance like this one• the circulating
antitoxin is of prime importance.
Tetanus toxoid should be administered at the time of
trauma as most all people who are immunized respond rapidly to
the 1t,booster injection" within the incubation period of the di seas
which may be only five days.
The work of other investigators has clarified the
situation still further.

One pediatrician. Peshkin. has been

conducting series of immunizations for the past several years.
According to his work, the critical blood titre level is 0.01
•34-
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American units of antitoxin per cubic centimeter of blood. (M.

M. Peshkin - 1943)
The children in his series had adequate basic immunity
after receiving two initial doses of combined diphtheria tetanus toxoid.

When the "booster dose" is given two years

after basic immunization. an adequate protection by blood titre
develops within one month which is higher and lasts longer than
when the •booster shot• is given from three to fffl;een months

after basic immunization.

The antitoxin titre is adequate on

the seventh day after giving the third injection; and in most
instances. the titre is at its maximum level.

In another series of children. similar studies are
undertaken; only• this time the third dose of toxoid is given
three years after basic immunization. (M. M. Peshkin - 1944)
A similar response results.

At the end of one year after the

injection. one hundred percent of the series still had an
adequate immunity.
Studies on another group of twenty-five children who
received the "booster dose" four years after basic immunization
show that seven days after the injection the blood levels of

0.2 units are present. (M. M. Peshkin - 1945)

One year later

seventeen children, who were available out of the group of
twenty-five,

still have an adequate blood titre.

This obser-

vation is very important as there is no cutaneous test to
determine the status of immunity, and blood titrations are an
-35-
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impractical laboratory procedure.
The following tables are the composite results from
the foregoing series of immunisations.
Table Number VII
The Average Levels of .Antitoxin Titres One Year After the
Booster Dose tor the Four Groups of Children
Group

Level of Antitoxin Titre

4 years

0.24 units

3 years

0.373 units

2 yea.rs
3 months to

0.298 units

15

.

0.083
Table Nmnber VIII

The Percentage of the Various Groups of Children in Which the
.Antitoxin Titre Dropped to Inadequate Levels
Group
4 years
3 years
2 years
3 months to
15 months

Level of .Antitoxin Titre

0%
0%
3%
7%

The conclusions reached are that the ttbooster dose"
of alum precipitated toxoid should be given only two or more
years after the completion of basic immunization with two doses

of combined toxoids.
A plan suggested to eliminate the low levels

or tetanus

antitoxin titre found one year after primary immunization involves
a shortening of the interval between the primary series and the
first •booster dose" of toxoid. (D. T. Fraser, D. L. MacLean, H.
C. Plummer, and F. O. Wishort • 1943)
rapid increase in t he antitoxin titre.

This ohange causes a more
This "booster dose" should

not be given in less than three nor more than six months after bas:
immunization; then a second booster dose is given fifteen to eigh
teen months after completion of the primary series.
The speed with which the antitoxin is produced in a
basically immunized person is of prime importance in ease
trauma.

or

In these instances, either fluid or alum precipitated

toxoid is recommended.

(J. J. Miller and J. B. Humber - 1943)

The response to the "booster dose"

or toxoid depends

on the following factors;
1. The type of basie immunization.
2. The interval after the last injection - an unoontroll
able variable in the case of trauma..
3. The type of toxoid used as a stimulus.
4. The dosage used.

s.

The individual's immunity mechanism - a greatly

variable factor.

Table Number IX
Speed of Increase in Antitoxin Following Reinjection with
Either Alum Precipitated or Fluid Toxoid
,umber of Days After Injections
5
7
6
2
3
4
1
IReinj ected1 Increase
with
fluid
No
toxoid
Increase
Reinjected Increase
"ith alum
orecipi tat- No
ed toxoid Increase

8

1

3

3

10

1

10

1

5

6

7

Total No.
of Children
2,0

1
35
2

!

(Note: In all oases, the last injection was given 12-15 months
previous to this injection.)
The conclusion

reached is that in case of trauma the

injection of a "booster dose" of fluid toxoid gives a more
rapid rise in the antitoxin titre.
In one author's experience, no one has failed to
develop an immunity after three doses of one-half cubic centimete1
of toxoid. (R. Spaeth - 1942)

The immunity appears about two

weeks after the second or third dose of toxoid.
Another investigator recommends three subcutaneous
injections of one cubic centimeter of toxoid at three to four
week intervals. (J. H. Lyons - 1944)

This method confers an

immunity for twelve to eighteen months.

He recommends that a

"booster dose" of one oubio eentimeter of toxoid be given a
year from the completion of the primary series and once a year
thereafter and at the time of injury.
A note of warning is necessary as regards the effect
-38-
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of passive immunization on active immunization procedures.

Any

considerable quantity of injected antitoxin prevents the development of primary sensitization or the primary response of the body
cells by doses of toxoid injected during the first week of
procedures so that later a single dose of toxoid is ineffective
in stimulating the active production of antibodies. (J. V. Cooke
and F. G. Jones - 1943)

Only when the passive antitoxin titres

have reaohed a relatively low level is active immunization

effective.

This condition is due to the inhibition by the

heterologous antitoxin of the antigenic action of the toxoid.
A delay of two to four weeks in the active immunizing procedures
is necessary following an antitoxin injection.
These observations refute the value of the simultaneous
serovaccination procedures.
The use of tetanus toxoid has another great advantage
over tetanus antitoxin - it avoids the real dangers of reaction
or sensitization incident to serum administration. (R. A. Cooke,
S. Hampton, W. B. Sherman, and A. Stull - 1940)
Looal reaotions are few• about one percent of the
oases. (L. Unger -1942)

Systemic reactions are rare.

test is usually of some help.
urtioaria or shook.

The skin

The reactions seen are usually

No fatalities are recorded as yet.

The presence of allergy is no contraindication to the
use of tetanus toxoid.
There are several routes for the administration of
-39-

the toxoid.

The intracutaneous route has the advantage of pro-

ducing less local reaction than the subcutaneous route while
producing antitoxin levela higher than that produced by the use
of antiserum.

These levels, also, last longer. (T. B. Friedmann,

J. A. Bigler, and M.A. Werner - 1942)

The intradermal injections seem to give more local
reactions than do the intramuscular injections. (L.A. Yeazell
and

w. c.

Deamer - 1943)
Severe reactions occur in about

cases. (J. H. Lyons - 1944)

1/10,000-so,ooo

The patient should be kept under

observation for a half an hour after being given toxoid.

A

syringe of adrenalin should be handy.
There is no difference in the antitoxin producing
ability of the allergic child as compared with that ability of
the non-allergic child of the same age and sex. (T. B. Friedman,
J. A. Bigler, and M. A. Werner - 1942)

The variation found among

allergic children is comparable to that found among non-allergic
children.
There is no danger in administering tetanus toxoid
to allergic children.

The stimulating dose of the toxoid gives

a rapid and high response of antitoxin.

Sensitization is not

present among 109 allergic children nor in a similar group of
non-allergic children.
Active immunization against tetanus or diphtheria in
allergio children has no apparent effect on the allergic
-40-
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manifestation. and concur.rent allergic therapy has no effect
on the antitoxin levels produced.
The skin test is advooated by some men as a method
of avoiding reactions.

In a group of adolescents, thirty-eight

percent of the group with positive skin tests have asth..�a or
hay fever; and about fourteen percent of the asthmatics have
strongly positive skin tests. The local and systemic reactions
are no more frequent among those individuals with a positive
skin test than those without a positive test. (J. R. Gallagher,

c.

D. Gallagher, and G. G. Kaufman - 1942)

Those people with

strongly positive skin tests had received divided doses of
toxoid. Thirty-six percent of those individuals with strongly
positive skin tests gave no history of allergy. A nwnber of
those subjects with a negative history and a negative skin test
gave unfavorable reactions. Neither the skin reactivity nor the
history of allergy is a strong reliable indicator of possible
local or systemic reaction.
Table Number X
Reactions to Tetanus Toxoid in People with a History of Allergy
and without a History of Allergy

I

History
of
Aller.,.,,
No History
A, ,Qf_.
TOTALS

TOTAL , Sore 1 Arms
Ma.ldse
NO. No.of % No.of %
CASES Cases
Cases
75

16

21.3

3

4.0

434

75

17.0 16

3.7

509

91

19

Infirmary Ab- Urti·
.Admis&ions cess oaria
No.of % No.of No.of
(! ...... l"!acw1
Cases
,.

2

2.7

0

0

10

2.3

2

1

2

1

12

(Note: In Table NumberX, page 41, 3.7% of the group had a
strongly positive skin test to the diluted tetanus toxoid.)
The work of another investigator shows that one case
of urticaria was encountered in a group of thirty-one children
who were immunized and then given a "booster shot" of combined
diphtheria and tetanus antitoxin two years after basic immunization. (M. M. Peshkin - 1943)
In this same group of children twenty-two percent of
the thirty-one gave a temperature for two days.

Only three

percent of a group of children who received a "booster shot"
of combined toxoids three to fifteen months after basic
immunization gave a temperature.

Work by this same investigator

on children who received a "booster shot•• of combined. tox:oid
reveals that no febrile or allergic reactions occurred after
the injection - only three children had a moderate and one child
a severe headache. (M. M. Peshkin - 1945)
The composite work of this investigator reveals that
febrile and allergic reactions occurred only with the injection
of combined alum precipitated diphtheria and tetanus toxoids•
therefore, alum precipitated toxoid should be used alone for the
1

•booster dose" when basic immunization has been produced with

combined diphtheria and tetanus toxoids.

This procedure will

keep febrile, marked local, and systemic reactions at a minimum
level.

-42-

I

Table Number XI
Percentage of Reactions Occurring with the Injection of Combined Alum Precipitated Diphtheria and Tetanus Toxoids varying with the Duration after Basic Immunization
Duration after
Immunize. ti m
3-15 months

Percentage
of Reactions

3%

2 years
3 vears

22%

33~

In 186 allergic children who had received from two
to five doses of combined toxoids, there were sixty-one children
who received a third dose of uncombined tetanus toxoid.

For a

total of 534 injections, the incidence of reactions was 0.37
percent.

Scratch tests done on all of the children of both

single and combined toxoids did not produce positive reactions
in any of the children observed.

These skin tests were done both

prior to the third dose and from one to six months following it.
The conclusions reached were that a ffbooster shottt of alum
precipitated tetanus toxoid be given only two or more years
after completion of basic immunization with two doses of combined
toxoids.
Another investigator recommends a similar plan for
immunization but recommends three doses of toxoid be given initial
(L.A. Yeazell and

w.

C. Deamer - 1943)

With ~1is latter method

of immunization, a note is put on the certificate of immuni~ation
which reads as follows,
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"To the Parent:
immunization.

Your child has received recorded

If he has received injections against whooping

cough or tetanus (lockjaw), he should receive a boosting injection against each of these infections not over two (2) years
later.
If at any time because of injury it is necessary to
raise his immunity, show this card to the doctor caring for the
injury."
"To the Physician:

If the above record shows that

this patient has received basic immunization against tetanus
(two (2) injections or more), we suggest, if possible, in case
or injury calling for protection against tetanus, he receive an
injection of tetanus toxoid (plain or alum precipitated) instead
of tetanus antitoxin.

It should be given promptly within twenty•

four hours of the injury."
There are some records reporting sensitizations with
the old Witte toxoids. (R. A. Cooke,
and A. Stull - 1940)

s.

Hampton,

w.

B. Sherman,

These anaphylectoid reactions resulted

from toxoid prepared from toxin produced on Witte's peptone •
veal infusion - glucose media.

The potency of this toxin is

100,000 M.L.D. per milleliter. (E. M. Taylor - 1945)

A new

media (hog stomach autolysate and beef heart infusion) for the
production of' the toxin has given no anaphylaotic reactions after
extensive use for four years.
The results from the use of tetanus toxoid during the
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World War II have been gratifying.

The program of immunization

began in the United States Army in June 1941.

No cases of

tetanus were reported from battle casualties. {Major A. P. Long 1943)

Sinoe June 1941, only four cases of tetanus have developed

in the whole army; and these cases were in non-immunized men.
At the same time other types of anaerobic infections have
developed in areas where the toxoid was used so tetanus per se
was always a potential threat.
From the British records, similar results have occurred.
During the campaign in Flanders and Dunkirk, about ninety percent of the British Expeditionary Forces were immunized.

In 1800

non-immunized, wounded men, eight cases of tetanus developed.
In 16,000 actively immunized men, no case of tetanus developed.
Because of circumsta.noes, no antitoxin was given in any case.
(H.B. Schumaker and A. Lamont - 1942) (H.J. Bensted - 1940)
As was seen under Bacteriology, the distribution of
the teta.ni bacilli is widespread.

In swabs taken from wounds

of 214 patients of the Middle Eastern Theatre, sixty-three
patients had gas gangrene; but none of them had tetanus. (J.
Boyd and J. Maclennan - 1942)

About eighteen of these swabs

had the Clostridium tetani organisms.

Of swabs taken from the

wounds of 494 wounded, two swabs had positive cultures; but there
were no cases of tetanus present.
In the well immunized troops from the United Kingdom,
Australia, New Zealand, and India, the incidence of tetanus per
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thousand wounded was 0.13 percent.

Four cases of tetanus de-

veloped - two cases in the Maoris and two oases in the Indians.
One of the latter group was not immunized.
The South African Force was not so well immunized either as early or as completely.

The incidence or tetanus among

these troops was 1.6 per thousand wounded.
During the first two years of the Mic.dle Ea.st War.
eighteen oases of tetanus developed; five cases developed in
actively immunized men.

Two of these oases recovered, and the

other three cases died.

In one of these latter cases• there

was little or no response to immunization with two doses of
toxoid.

This situation reflects the need of a third dose.

The

other two fatalities had overwhelming infections from masses of
necrotic tissue in the wound.

This situation emphasizes the

need of adequate surgery.
There is another case of a fatality due to tetanus
in an actively immunized man; but after scrutinizing the record 11
it is seen that this person was not fully immunized with toxoid
before he developed the tetanus. (R. J. McGill - 1943)
From the foregoing information. the value of the use
of tetanus toxoid can be derived.

A committee set up to study

the problem oame forth with the following recommendations: (Committee Report -1944)
1. There is administrative economy and efficiency in
the use of multiple antigens.
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2. The administration of' plain or altmt precipitated
tetanus toxoid by itself in the pre-school group as a routine
praotice is not recommended.
3. The use of tetanus toxoid in combination with

diphtheria toxoid is approved in this age group.
4. The administration of' tetanus toxoid at any age

is recommended, provided the environmental (social or occupational:
conditions demand i:mmunity.

s.

The time for the administration of' the ~ooster shot"

is undetennined as yet.
THERAPY

Every case of' tetanus is a grave emergency, and no
time should be lost in instituting treatment regardless of how
mild the case appears to be. (J. K. ca1v1n - 1941)
The actual therapy can be divided into four general
divisions.
1. Nursing and symptomatic care.
2. Sedation.
3. Therapy with tetanus antitoxin.
4. Local treatment of the wound.
A standardized routine is a necessity for the favorable
treatment of tetanus.

The treatment should be handled, if

possible, in a hospi -ta 1 by a trained team of' experienced physician,
and nurses in the handling of' this disease. (R. Spaeth - 1942)
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The patient should never be left alone.
constant attendance.

A

A

nurse should be in

quiet ward and a darkened room are

essential features in this routine.
Sedation is the keystone of the therapy.

Sedative

therapy is to prevent or control convulsions and is indicated
before attempting to carry out any other procedure.
Calvin - 1941)

(J. K.

Sedation tends to prevent early death from

suffocation_ rapid aspiration pneumonia, or more rare - brain
hemorrhage. (R. Spaeth - 1942)

It is dangerous to omit sedation

even in mild cases of tetanus.
The ideal antispasmodic should rapidly relax the patient
enough to allay the convulsions and rigidity without complete
loss of consciousness or collapse from the drug. (J. K. Calvin 1941)

If possible, the cough and pharyngeal reflexes should not

be abolished.
Many drugs have been used to produce this sedation.
Each drug has its champion defender.

The more widely used drugs

are contained in the following list.
le Avertin
2. Sodium amytal and other barbiturates
3. Amylene hydrate
4. Chloral hydrate
5. Magnesium sulfate
6. Opiates
7. Sodium bromide
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8. Inhalrmts
The inhalants are apt to produce fatalities more

s.

often. (V.

Caviness - 1943)

All of the drugs listed above are respiratory depressants of one sort or another and exert some influence on
the respiratory center in the medulla oblongata.

According to

the discussion of the pathological physiology of the disease,
these drugs are apt to hasten the lethal action of the new
proposed tetanus toxin.

nw.

M. Frior, H.B. Schumaker, and A.

Lamont - 1940)
In view of this foregoing knowledge, the use of
curare would seem to be the ideal drug to obtain good muscular
relaxation.
than central.

The site of action of the drug is peripheral rather
(S. C. Cullen and C.

s.

Quinn - 1943)

The action of this drug is to interrupt the synoptic
transmission of the nerve impulse at the myoneural junction by
depressing the nicotinic action of aoetylcholine.

This action

gives paralysis without central depression.
The use of this drug by this depressant action would
tend to disrupt the pathologic physiology of this disease as
was discussed under the division of physiology. (A. M. Harvey 1939)
Curare affects the skeletal muscles in the following
order. (S. C. Cullen and C.

s.

Quinn• 1943)

1. Cranial nerves.
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2. Muscles of trunk and extremities.
3. Muscles of respiration.
4. Diaphragm.
This drug makes possible the release of the asphyxiating toxic fixation of the chest without the complete paralysis
of the respiratory muscles.
Curare may be capable of acting anywhere in the nervous
or muscular systems where acetylcholine is the chemical mediator.
(E.G. Gross ands.

c.

Cullen - 1945)

Therapeutic amounts of

curare cause relaxation of the smooth muscle of the small intestine in experimental animals.

This effect is due, in part,

to the direct effect on the effector cells of the muscle.
Curare oan produce a hypotension, but this reaction
is probably of peripheral origin caused by the relaxation of
skeletal muscles and the resulting hypotonia causing a decreased
venous return.
These foregoing observations suggest that large single
doses of curare should be avoided.
The elimination of the drug occurs within two hours.
Partial destruction of the drug takes place in the liver, and
partial elimination of the drug occurs in the kidneys. (M. F.
Mallinson - 1945)

Kidney lesions do not contraindicate the

use of this drug.
The use of curare in anesthesia shows there is an
absence of toxicity either immediate or postoperative. (H. R.

-so-

Griffith - 1945)

The drug has been given to anemic, frail, or

shocked patients without harm.

Doses up to 400 milligrams have

been given without fatal results.
Curare is not effective by mouth and should be given
either intravenously - the most widely used route - or intramuscularly.
In pediatrics at the present time, standardized curare
is used as an adjunct to surgical anesthesia and in the treatment
of spastic paralysis. (C. F. Church - 1945)
The various side reactions of curare - such as bronchial
spasm and hyperseoretions • are not troublesome.
The literature reports that forms of unstandardized
curare were used as far back as 1934.

The use of the drug has

been retarded because of the lack of a standardized product.
The list of the case reports using curare is as follows.
1. Tetanus treated with curare. (L. Cole• 1934)

The

dosage consisted of four doses of thirty-two milligrams of un•
standardized curare given subcutaneously at six-hour intervals.
The drug began acting within two hours and lasted about fortyeight hours.

Good results were obtained, and the patient was

allowed much comfort.
2.• Case of tetanus treated with curarine. (J.
1935)

s.

Mi tche

The dosage consisted of .1 milligram initially and .1

milligram every four hours for the first day.
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The dosage was

gradually increased eaoh day until eight doses of 0.5 milligrams
were given in a twenty-four hour period. The total dosage for
the period of twenty days was 48.l milligrams of unstandardized
curarine.

Good results were obtained.

No bad effeors were seen.

Repeated eleotrooardiogra.ms showed no abnormalities even when
taken immediately after the injeotion of the drug.
3. Case of intravenous ourarine in the treatment of
tetanus. (R. West - 1936)

The dosage in this ease consisted

of an inflow of eurarine of 0.25 milligrams per kilogram body
weight per hour.

This clinician reoormnended the use of this

drug in advanced oases of tetanus.
He, also, states that when the incubation period of
the disease is under seven days or the periof of development of
generalized convulsions is less than three days, death is to
be expected whatever the type of treatment adopted.
4. Curare in the treatment 0£ tetanus. (S. E. Isacson
and S. A. Swenson - 1941)

These men used an a queous solution

of ten milligrams of the 0�1de drug per cubic centimeter, and
they started with four eubio centimeters of the solution inject,
intravenously. 1th.en the effects began to wear off - a period
of about an hour, three oubio centimeters of the solution was
i�jeoted.

In about an hour, two oubio centimeters of the solut

were injected.

They attempted to establish a maintenanoe dose

of four oubio centimeters, aooording to the response of the
patient.

Good muscular relaxation was obtained and better
breathing occurred due to the relaxation of the respiratory
muscles.

The patient seemed more comfortable during the

course of the disease.

s.

c.

Cullen and

The use of curare in the trea-bnent of tetanus.

c. s.

Quinn - 1943)

(s.

The preparation used was

intocostrin (extract of unauthenticated curare).

The drug was

supplied as an extract, standardized by biological assay to
contain 0.02 grams per cubic centimeter of a standard drug.
There was no apparent difference in duration of the effect produced by intravenous and intramuscular injections.

The onset

of action was more rapid with intravenous administration.
Usually 0.050 grams of curare kept the patient comfortable and free from acute spasm for about three houra.

The amount

of drug administered was determined by the response of the patient
About 0.008 to 0.010 grams of curare per kilogram body weight
was satisfactory.
Marked relief was experienced by the patient.

The

patient was able to cough, expectorate, drink, and move ab?ut
in bed.
From the foregoing case •history, the plan of dosage
of ourate is drawn.

Use 0.010 grams of intocostrin per kilo-

gram body weight by either intravenous or intramuscular injection
as indicated by the response of the patient - especially by the
tone of the rectus abdominus muscle •
..53 ...
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The administration of the drug needs experience in
handling it and should have the following items on a stand-by
basis.

(s. c.

Cullen and

c. s.

Quinn - 1943)

1. Anesthetic face mask
2. Rebreathing bag
3. Oxygen supply
4. Physostigmine and prostigmine methylsulfate

1-2 cubio centimeters of 1:2000 solution (C. F.
Church - 1945)
5. Experience in administration of artifioal respiration.
This drug gives adequate control of the muscle spasm
plus a patient who is awake, able to move, able to void and
defecate, and able to respire freely.
The effects of prol:>nged curarization are not known
as yet.

In experiments done on dogs, the postmortem findings

revealed the heart - especially the right side -was consistently
dilated and the liver and kidneys congested. (M.A. Perlstein
and A. Weinglass - 1944)

Atropine appeared to hasten the cause

of death which may have been due to ventricular fibrillation
caused by removal of the vagal nerve inhibitions.

Atropine,

also, delayed decurarization by neostigmine.
More information concerning the clinical application
of curare is now becoming available due to its standardization
and to its use as an adjunct in surgical anesthesia.

The drug

seems to be full of promise for the treatment of tetanus.
The

third phase in the treatment of tetanus is the
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use of tetanus antitoxin.

As reviewed under passive immunity,

there are many routes for the administration of the antitoxin.
The literature. also shows quite a variation in the amount of
antitoxin to be used seemingly without any rationale behind the
dosages advocated.
The old routine of using successive massive doses of
antitoxin is slowly being discarded as impractical, expensive.
and dangerous.

The use of 40,000 to 60.000 units of antitoxin

in a single massive dose intravenously is a much more logical
procedure. (R. Spaeth - 1942)

Antitoxin given in this manner

will rapidly reach and neutralize any unfixed tetanus toxin.
(J. K. Calvin - 1941)

This antitoxin should be diluted in at

least 500 co. normal saline and given slowly to avoid reactions.
The use of 5% dextrose or Hartman's solution is acceptable.
The rate should not exceed sixty drops per minute. (R. Spaeth 1941)
A quick review of the discussion of the passive
immunization shows that the blood titre after the injection
of 10,000 units of antitoxin is at the protective level of
0.10 units for four to six weeks. (J. V. Cooke and F. G. Jones 1943)

A method devised to help reduce reactions after the
administration of antiserum is as follows. (R. Spaeth• 1941)
1. A hypodermic of atropine sulfate with epinephrine
hlOOO given thirty minutes before the use of anti toxin.
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2. The dosage should vary with the age group involved.
Table Number XII
Dosage Schedule for Atropine Sulfate and Epinephrine 1:1000 for
Various Age Groups
DRUG
Epinephrine
1:1000

AGE GROUP
5 years
6 months
2 years
5 minims
3 minims
4 minims
or 0.18 cc. or 0.25 cc. or 0.31 cc

Atropine
Sulfate

grains 1;5(1) grains 1/4,C grains 1/400 grains 1,/2. 00
or O. 12 mgm. or 0.24 mgm. or 0.3 mgm. or 0.6 mgm.

adult
8 minims
or 0.49 cc.

There are several definite indications for the use of
tetanus antitoxin. (R. Spaeth - 1942)
1. Blank cartridge and powder injuries.
2. Penetrating wounds.
3. Dirty lacerations.
4. Self induced or improperly performed abortions.
5. Soil contaminated wounds.
Usually, the local signs of tetanus appear in the
injured limb before any generalized symptoms appear.

This

happening is an important warning that generalized tetanus will
almost certainly appear and that antitoxin should be given immediately without waiting for further signs. (L. Cole - 1945)
Some people reject the use of antitoxin entirely and
do so on three basic reasons. (P. Campiohe - 1943)
1. The value of antitoxin has not been prov~n.
2. Cases of tetanus are known to appear after the
prophylactic use or antitoxin.
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3. SerUI'l reactions are dangerous to the patient.
The fourth division in the treatment of tetanus is
the care of the local lesion.

Some men contend that the case

of the local lesion is not an emergency. (R. Spaeth - 1941)
The wound should be treated as it would be treated if tetanus
was not present.
The care of the lesion is. in another man's eyes, the
first principle in the treatment of tetanus. (J. H. Lyons - 1944)
This investigator believes the condition is a surgical situation that requires aseptic technique.
Nearly everyone agrees on certain basic principles.
1. Debridement of all devitalized tissue.
2. Removal of foreign bodies.
3. Drainage of pus.
4. Leaving the wound open.
5. Irrigations with a cleaning and oxidizing bath.
6. Amputation if necessary.
The use of oxidizing substances facilitate drainage
but do not destroy the tetanus bacilli locally. (R. Spaeth - 1941)
The failure of these substances may be due to the reducing value
of the tissues. (J. H. Lyons - 1944)

Cauterization is contra-

indicated as this procedure devitalized tissue.
The less the discomfort the patieht has and the less
the disturbance endured. the better the situation is for the
patient. (R. Spaeth - 1942)
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It might be well to cradle the bed clothes to decrease
the irritation to the patient. (L. C. Cole O 1940)
At times. not even the combination of wound excision
and serum injection is able to prevent tetanus.

This might be

due to a particularly high virulence of the organism. (E. Koenig 1940)
These fatalities may also be due to the unwillingness
of the practioner to submit the patient to extensive surgical
treatment for slight wounds. (R. Spaeth - 1942)

Multiple local

wounds are an indication for multiple incisions.

In spite of

the removal of foreign objects, some spores persist.
In some cases. the tetanus bacilli may gain entrance
to the body through undetected trivial wounds.
The development of new drugs in the past few years cause:
new hope and speculation in the treatment of tetanus.

The

evaluation of the usefulness of these drugs is not yet possible
as the medical literature is still too sparse on the results of
their use.
The use of the sulfa drugs has shown varying results.
1. A survey of thirty-five oases of' tetanus shows
favorable result with the use of sulfapyradine in connection with
evipan-sodium as the antispasmodic.

This line of treatment is

cheaper than serum therapy and should prove to have a place in
the treatment of severe tetanus. (S. M. Ghosal and L. M. Chaudhury - 1942)
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2. In a severe case of tetanus, incubation period of

forty-eight hours, the administration of 520,000 units of tetanus
antitoxin, sedation with sodium amytal and avertin, and an adequate blood level of sulfanilamide did not result in clinical
improvement. (C. B. Penrod and A. E. Knoll - 1941)
3. Sulfanila.mide contaminated with tetanus spores

and implanted in a guinea pig will not protect these animals
from the development of tetanus.

The sulfanilamide may act as

a tissue debilitant; and, in the presence of Clostridium tetani,
the drug may be conducive to the development of tetanus;. therefore, the sulfa powders for use in deep wounds should be sterilized

(H. Welch, G. G. SolcUin, and R. P. Harwick - 1942)
Penicillin has shown some experimental evidence that
indicates it is of value in tetanus.

(W. E. Herrel, D.R. Nickols,

and D. H. Heilman - 1944)

In a report on two oases of tetanus, it was deemed
apparent that the addition of penicillin to a large dosage therapy
of tetanus antitoxin was a life-saving measure.

(R. Buxton and

R. Kunnan - 1944)
Another clinician reports a case of tetanus treated
successfully with massive doses of tetanus antitoxin and penicillin.

(J.M. Albergotti - 1945)
Another case of successful treat:nent reports the use

of avertin and penicillin.

This author notes that the penicillin

has no action on the toxin of tetanus. (H. A. Toyne and P. E.
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Voss - 1945)
The development of the antibiotus also bears watching as regards the treatment of tetanus.

In some work done on white mice, the evaluation of the
action of penicillin, clavacin, and streptomycin on tetanus
toxin shows some interesting results.

(E. Neter and D. Will -

1944)

The tetanus toxin was mixed with 100 units of sodium
penicillin and injected immediately or after eighteen hours at
icebox temperatures into white mice.

The tetanus toxin thus

prepared was as toxic as tetanus toxin injected alone.
The use of ten milligrams of streptomycin incubated
for two to forty-eight hours at 37°0. with tetanus toxin did
not reduce the toxicity of the toxin.

Clava.cin, alone, in the

amount of 1.5 milligrams proved to be lethal for mice.
A mixture of 2.5 milligrams of clavacin and tetanus

toxin and incubated at 37°c. proved to be non-toxic when .2
milliliters of a 1:10 dilution was injected into mice.

The con-

trol mice injected with diluted tetanus toxin died of tetanus;
therefore, it seems that 0.2 milligrams of clavacin delayed death
in mice due to tetanus.
Tyrothrioin (Gramicidin and Tyrocidin) in amounts of
0.05 milligr9.llls or less has no immediate effect on the toxicity

of tetanus toxin. (E. Neter - 1942)

If the toxin has been diluted

with physiological saline solution and incubated at 37°0. for
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24 hours, then, varying amounts of tyrothricin (from 0.05 milligrams to 0.000005 milligrams) partially or completely inhibits
the toxicity of the diluted toxin.
Actinomyoin A. has no effect on the toxicity of the
tetanus toxin.
Pyocyanase, in a.mounts of one milligram, inhibits
the toxic and lethal effects of tetanus toxin in the presenoe of
broth.
Zephiran inhibits tetanus toxin in the presence of infusion broth or human serum.
Zephiran chloride in concentrations which are bacteriostatic or bacteriocidal in vitro and in vivo, i.e., 1:2000 inhibits the effect of tetanus toxin. (E. Neter - 1942)
inactivation of this toxin takes place immediately.

The

The presence

of human serum definitely interfers with this inactivation.
Human serum in 1:100 dilution added to a mixture of zephiran
chloride and tetanus toxin prevents the inactivation of the toxin
while a 1:1000 dilution of serum does not.
Phenyl ~ercuric acetate antiseptic in pellets contaminated with tetanus spores delayed the development of tetanus but
does not prevent it. (H. Welch, G. Slocum, and J. J. Durrett 1942).

The implantation of pellets in deficiency diseases is

a hazard if the pellets are not sterile.

The incorporation of

antiseptics to prevent tetanus into such pellets during the
manufacture is a useless procedure and is dangerous.
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The general phases of the treatment of tetanus have
been reviewed and corrected according to current trends.
A recommended scheme for the treatment of tetanus will
now be set forth as seems feasible to the author.
1. Nursing and hospital care as recommended in the
general considerations.
2. Sedation - curare for the reasons discussed.
Dosage - 0.010 grams per ki. logram as
often as indicated.
3. Serum therapy - one (1) dose of 50,000 units of
antitoxin I.V. ·Skin test before administration.
4. Local therapy - moderate debridement of gross contaminants, and the immediate use of penicillin to control the
organism per se.
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START
History and Prodromal Symptoms

Case

# 45119
Male

Age 9
Race -

whi'b

Admitted 9/19/33

I 39619

Female
Age 7
Race - white

Admitted 7/7/32

# 57640
Male

7
Race - Whlte

Age

Admitted •
7/15/35

1. Ran sliver in right knee 9/9/33.
2. Jaw stiff and couldn't open mouth
9/11/33.
3. Taken to UID who said patient was
alright. No tetanus antitoxin.
4. Went to school 9/19/33 but teacher
called LMD at noon.
5. Incubation period - two days

1. Splinter of branch of tree ran in foot
6/7/32.
2. Foot was swollen & painful for two weEi(
3. Convulsion occurred 7/1/32. First
symptom. Several since.
4. Leg became spastic causing difficulty
in walking for 11 days.
5. Jaw not spastic except with oonvulsicns
6. Incubation period - about 21 days.

1. Horse stepped on foot in barnyard
injuring big toe of right foot 7/9/35
2. Mother applied iodine & bandage only.
3. Some swelling developed but no
suppuration.
Restlessness
developed in a.m. 6
4.
days later 7/15/45.
5. Jaws hurt at noon & couldn't open
mouth wide.
6. I.MD saw and sent to UNH
7. Incubation period - 6 days.

BRIEF SW.MARIES OF CASES OF TET.il'!US TREATED
in
THE UNIVERSITY OF NEBRASKA HOSPITAL
OW.I.AHA, NEBRASKA
Admission Symptoms & Physical Findings

Treatment

1. Sedation
l.Sodium luminal
2.Magnesium suli.te
3.Codeine sulfate
Old wound - medial side of right knee 2. Serum therapy
Moderate doses of
antitoxin I.V.,
I.M., & intraspinously.
Total,85,000 mits

l. Talks without opening jaws.

2. Jaws stiff'.
3. Neck muscles stand out prominantly
4. Abdominal rigidity - no tendernesa

s.

I
;

.

I

1. Spastic right leg.
2. Stiff jaw.
3. Cannot or will not open jaw.
4. Difficulty in suppressing tongue.
5. Crusted lesion below right patella
6. Healed wound on plantar surface of
right foot.
7. Right foot - plantar flexion with
some inversion.
8. Srastio gait with right leg.
9. Negative neurological examinetiona.

1. Soreness of jaws & inability to open

II

I

them.
2. Restlessness.
3. Mouth open¼ of way.
4. Jaw muscles in spasm.
s. Pain on palpation of face.
s. Swollen big right toe.
1. Necrotic tissue about the toe nail.
2. No apparent suppuration.

1. Sedation
Hone
2. Serum therapy
Repeated moderate
doses or tetanus
antitoxin
Total - 50,000

units

11•I.Phenobarbital
Sedation

2.Codeine sulfate
2. Serum therapy
l.Ten thousand
units intraspinously.
2.Forty thousand
units-divided
doses intramuscularly.
Total - 50,000
units

Clinical Course
1.
2.
3.
4.

LI

Termination

1. Urine -

1. Improved.
Patient had convulsions.
Urticaria developed on ninth day. 2. Dismissed 10/4/33.
Duration - 15 days.
Gradual improvement.
Temperature gradually dropped
from 102 °F to 99 0F.

2. Blood

Hb.

RBC

WBC
Seg
StaJ
Lym:
Mon,
Bas,

3. Spinal

I

9/21

9/2

1. Developed a rash 10 days after
admittance.
2. Red blotchy areas on shoulders
and buttox, later became
generalized.
'

'

s

4. Nose &

for dip:

1. Improved.
,2. Dismissed 7/21/32.
Duration - 15 days.

1. Urine 2. Blood
Rb.

RBC

3. Urticaria present 13 days after
admittano e.
4. Temperature ran 101°F down to
99 .8°F.
5. Patient never seemed restless
in the hospital.

1. Patient developed serum sickness 1. Improved.
2. Dismissed 7/24/JS.
on 2 ocoasions.
Duration - 9 days.
2. Patient improved.
Diagnosis
of tetanus not
3.
3. While in hospital patient
positive.
developed acute tonsillitis with
pharyngeal oellulitis and
cervical lymphadenopathy oontrolled by hot saline irrigations.

3.

1iBC
Nose &

for dip

1. 'Grine •
2. Elcoci

I

E.b,
R'Q.t
WB(
-\

Se1
Stl

L�'l
Moi
3. Spinal
Pr

FINISH
nation

.0/4/33.
- 15 days.

'

I

Laboratory Work
1. Urine - essentially negative
2. Blood
Hb ••••• 90%
RBC •••• 5.5
WBC. • •• 23 .050
Seg •••• 87
Staph •• 2
Lymph •• 5
Mono ••• 5

Baso ••• l
3. Spinal fluid
9/20/33 - cloudy
8,880 cells/cu.mm
97% polys
9/23/33 - clear
185 cells/cu.mm.

4. Nose & throat cultures negative
for diphtheria bacillus.

/21/32.
- 15 days.

I

1. Urine - essentially negative

1

Autopsy Findings

'

None

I

I
'

None

2. Blood
Hb ••••• 80%
RBC •••• 5 .1
WBC •••• 7,500
3. Nose & throat cultures negative

for diphtheria. bacillus.

/24/,35.

1. Urine - essentially negative
2. Blood

- 9

Hb ••••• so%

~

RBC •••• 4.0

days.
tetanus not
positive.

vVBC. • •• 9, 140
Segs ••• 62

Staph •• 24
Lymph •• 10
Mono ••• 4
3. Spinal fluid
3 cells/cu.mm.
Protein 7

None

START
History and Prodroraal Symptoms

Case

#

60122:

Female
Age 15
Race - white

Admitted ..

3/20/38

,J..

2.
3.

4.
5.
6.

7.

a.

#

75993

Ma.le
Age 9
Race - white

Admitted ...
8/13/42

# 76160
Female
Age o
Race -white
Admitted ..
8/29/42

-

Fell on weed stubble and punctured lower
inner aspect of right thigh 3/8/38.
Removed splinter but leg bees.me sore and
stiff'.
LMD advised hot packs 3/1%38.
Developed signs of cold 3 16/38.
1. Soreness of throat on swallow:ing.
2. Inability to open mouth wide.
3. Stiffness and soreness of baek.
Legs and neck became stiff 3/17/38.
Chewing became difficult.
Symptoms of 3/18/38 1. Neck drawn back.
2. Spells of arching of back.
3, Stiffness of body.
4. Choking and blueness of face - spells
of 2 to 3 minutes.
5. Inability to eat solids.
Incubation period - 8 to 9 days.

1. Bruised lip on 8/7/42.
2. Ja.w didn t t work right 8/8/42.
3. Patient lethargic and had some facial
spasm 8/9/42.
4. Right eye became swollen.
5. Had 3 convulsions - a stiff neck preoeded the first one.
6. Incubation period - 1 to 2 days.

l. Ran sliver in foot which was partially
removed immediately 8/17/42.
2. Backache and trismus developed 8/27/42.
3. Incubation period - lC da.ys.

;
'

'

!

BRIEF SUMMARIES OF CASES OF TETANUS TREATED
i:n
THE UNIVERSITY OF NEBRASKA HOSPITAL
OMAHA, NEBRASKA

Admission Symptoms & Physical Findings
1. Moderate arching of back and retraction of neok.
2. Occasional twitching of side of mouth.
3. Sudden jerkings of trunk.
4. Bilateral nystagmus.
s. Inability to open jaws.
6. Rigidity and retraction of neck.
7. Abdominal rigidity.
8. Tenderness & pain on motion of spine.
9. Positive Kernig bilaterally.
10.Reddish-blue bleb 2 om. in diameter
with some induration on inner aspect
of' right thigh.

1.
2.
3.
4.
5.

Vague stomach aches.
Cramps in both popiteal fossae.
Neck partially stiff.
Abdominal spasm.
Semi-spasm of right face with some
trismus.

1. Trismus.
2. Neck rigidity.
3. Abdominal rigidity.

-

Treatment
1. Nursing care.
I.Tried to use
nasal tube for
feeding -action
caused too much
spasm.
2 .High Carbohydra.1:e
liquid diet.
3.I.V. fluids.
2. Sedation
l.Avertin.
2.Sodium amytol.
3. Serum therapy
!.Repeated massive doses of anti:toxin, I.V. & I .M �
4. Total doses.
195,000 units I.V
175,000 units r.s
5. Local therapy
l.Debridement &
removal of splin te ·
2.Hydrogen peroxide dressings.
1. Nursing care.
l.Diet by tube.
2.Fluids by clysis
Glucose,Laotate
rin.gers &: eevatim
3.Carbon dioxide
inhalation, 5 min
t.i.d.
2. Sedation
l •.Avertin
3. Serum therapy
100,000 units I.M
1. Nursing ca.re.
l.Diet-liquid by
tube.
2. Sedation.
l.Avertin
3. Serum therapy.
50,000 units I.M.

Treatment
1. Nursing care.
I.Tried to use

Clinical Course
1. Improvement noticed by 3/26/38.
2. Last anti toxin was given on

3/25/38 but m.aoulopapular rash
developed 3/29/38.
caused too much
3. Flaccid paralysis of lower exspasm.
tremities developed 3/31/38.
2.High Carbohydrate
Included loss of sensation from
liquid diet.
10th dorsal segment on.
3.I.V. fluids.
4. Distention developed.
2. Sedation
5. Neurologist diagnosed transverse
1.Avertin.
myelitis & treated with 200 cc.
2.Sodium amytol.
of 50% sucrose t.v. & spinal
3. Serum therapy
puncture. No improvement.
I.Repeated mass- 6. Temperature lOl0 to 104° at first,
stayed high until 4/10/38, then
ive doses of antigradually decreased to 911' F.
toxin, I.V. &: I.M,
4. Total doses.
195,000 units !.V.
175,000 units I.S
5. Local therapy
l.Debridement &
removal of splinte"
2.Hydrogen peroxide dressings.
1. Gradual d�pression of hyperactivity.
1. Nursing care.
1.Diet by tube.
2. Regular diet started 8/23/42.
2.Fluids by olysis
Glueose,Laetate
ririgers &: cevatim
3.Carbon dioxide
inhalation, 5 min
t.i.d.
2. Sedation
l •.Avertin
3. Serum therapy
100,000 units I.M 1. Hospital course was satisfactory.
1. Nursing care.
l.Diet-liquid by
tube.
2. Sedation.
l •.Avertin
3. Serum. therapy.
50,000 units I.M.

----------------------------------------:linical Course
Laboratory W
Termination
)Vement noticed by 3/26/38.
antitoxin was given on
/3a but maculopa.pular rash
,oped 3/29/38.
1id paralysis of lower ex
.ties developed 3/31/38.
1ded loss of' sensation from
dorsal segment on.
1ntion developed.
ilogist diagnosed transverse
tis & treated with 200 cc.
% sucrose L.V. & spinal
;ure. No improvement.
rature l0l0 to 104° a.t first,
,d high until 4/10/38, then

4
1. Urine 3/31/38
1. Tetanus recovered.
Color str-clear C
Dismissed 4/18/38.
Sp.G. 1.010
l
Duration - 29 days.
Ph.
Alk.
A
3. Residual changes Trace
T
Alb.
l.Flaccid paralysis & senso'.r"'J
Sugar 0
0
loss from level of xyphoid
l+
Acetone
l
prooess.
Misa. WBC occa.s. 5
2.Persistent slight urinary
infection.
2. Blood
3/20 3/21
3.lnability to pass feces.
95%
Hb
Must be manually removed
RBC
4.7
every day.
WBC 20,200 23,400 l
Seg
79

e.

Staph

ally decreased to 98' F.

�1 depression of hyper
ity.
ar diet started B/23/42.

1. Improved.
2. Dismissed 8/31/42.
Duration - 18 days.

-

10

Ljrnph 5
Mono
6
3. Spinal fluid
3/20 3/21
Cell <bunt 143 2100
- Protein
- Sugar
- Smear
Culture
negs.ti ve
KH.ne
Collod. gold - neg
Wassermann
.1- .2+ •

--

1. Urine - essentially
2. Blood 8/13/42
Hb
13.5
RBC
4.15
W13C
13,250
Seg
68
--------------1-----------------""f
Staph 10
Eosino l
,al course was satisfactory. 1. Improved.
Lymph 17
2. Dismissed 9/18/42.
Mono
4
,
Duration - 21 days.

__________

1. Urine - essentially
2. Blood 8/29/42
Rb
14.7
4.8
RBC
17 ., 680
WBC
No differential done,

FINISH
Laboratory Work
ion
------,1-----------....c-.
--------+l. Urine
Color
Sp.G.
Ph.
Alb.
& sensory
Sugar
rel of xyp hoid
·ed.
138.
,ays.
rs .ysis

ight urinary
pass reoes.
lly removed

back

3/31/38
str-clear
1.010
Alk.
Trace
0

Acetone l+
M.isa. Vi3C occas.
2. Blood

days.

cloudy
1.011
Alk.
Trace
0

l+

50/HPF

3/20 3/21
3/24
4/1
95%
Hb
RBC
4.7
\i'IBC 20,200 23,400 15,800 16,600
Seg
79
10
Staph LJ111Ph 5
Mono
6
3. Spinal fluid
3/20 3/21 3/31 4/6
8
Cell <bunt 143 2100 41
Protein
18
60
Sugar
102I\� 119Mg p
Smear
neg.
- neg.
Culture
neg.
- - neg.
Collod. gold - negative
Wassermann

1. Urine - essentially negative.
2. Blood B/13/42
Hb
13.5
RBC
4.15
WBC
13,250
Seg
68
10
Eosino l

Staph

/42.

days.

None

4/12/38

Kline - negative

/42.

Lymph
Mono

17
4

1. Urine� essentially negative
2. Blood
Hb

RBC

WBC

8/29/42
14.7
4.8
17,680

Autopsy Findings

No dif ferential done.

None

---------------None

START
Case

#

History and Prodromal Symptoms

1. Ran splinter in oheek 7/10/32.
39747
Female
2,. LMD opened wound on outside. Attended
Age 3
1-2x day. Treated with mercurochrome
Raee - white
and iodine.
3. Wound broke on inside of cheek 7/16/32
Admitted 4. Patient choked w hen swallowed water. Had
7/17/32
eaten nothing since 7/10/32.
5. Abscess lanced at hospital 7/16/32.
6. No tetanus antitoxin given at all.
7. Jerked convulsively during sleep past
three days.
a. Incubation period - 4 days.

#

45287
Female
Age 10
Race - white

Admitted 1:)/10/33

#

Admission Symptoms & Physical Find:
Temperature 103 ° , heart rate 180.
Pupils sluggish.
Infected wound right cheek.
Jaw stiff at intervals.
Tongue swollen and bruised.
Right cheek and neck swollen.
Throat filled with purulent materj
Thorax - dullness on right with bl
breathing and rales.
9. Somewhat comatose.
10.Resting restlessly.
11.Breathing is difficult.
12.Some oyanotic.
13.Upper extremities stiffen convulsj
ly at intervals •

1.
2.
3.
4.
5.
6.
7•
8.

1. Hands were _partly pulled through pulley 1. Stiffness and spasm of jaw.
2. Left hand had 1,2,3,& 4 fingers bs
on farm 10/3/33.
lacerated.
2. LMD i'lllll.ediately sutured the tendons and
Right hand had several minor lacei
3.
treated minor lacerations.
ations.
3. Developed some stiffness of jaw 10/9/43 •
4. Unable bo open jaw 10/10/,,:;s.
5. No antitoxin given.
6. Incubation period - 6 days.

1.
45500
1. Patient tell from wagon and lacerated
Male
scalp in parieto-oooipital region to the
2.
Age 50
bone 11/2/33.
Race - white 2. Right shoulder was dislocated & bruised. 3.
Occupation c. Bruises lower left chest and pain with 4.
laborer
respirations
4. Developed rigidity neck & jaw 11/6/33. . 5.
s.
Ad.rnitted 5. No antitoxin given.
7.
11/6/33
6. Incubation period - 4 days.
,s.

Rigidity neck & jaw muscles with i
ability to swallow.
Pain lower left .ohest with respira
Pain right shoulder.
Foul purulent drainage from scalp
laceration.
Rigid jaws and neck.
Neck drawn baok towards spine.
Spine not very rigid.
Extremities still flex.

BRIEF Slf.ooMARIES OF CASES OF TETANUS TREATED
in
THE UNIVERSITY OF NEBRASKA HOSPITAL
Oif..AHA. ., NEBRASKA

mpt_ o_ ms_ _&_P_h.,:y_s_i_ oa_ l_ _F_ i_n_d_i_ng-=-s_...,.___T_re_ _ atm_
_ en_ _t__-+_____c_11_no__
· a_1_c_o_ur_ s_ e_ ______,�
__A _dmis
_ _ s_i_on_ _S.:.y__:.
1.
2.
3.
4.
5.
6.
7•
8.

Temperature 103 ° , heart rate 180.
Pupils sluggish.
Infeoted wound right oheek.
Jaw stiff at intervals.
Tongue swollen and bruised.
Right cheek and neck swollen.
Throat filled with purulent material.
Thorax - dullness on right with bronclial
breathing and rales.
9. Somewhat comatose.
10.Resting restlessly.
11.Breathing is difficult.
12.Some cyanotic.
13.Upper extremities stiffen convulsive
ly at intervals.

1. Breathing became more & more
1. Nursing care.
l.Material aspir
difficult.
ated fr� throat. 2. Pulse became rapid & irregular.
2. Sedation.
3. Temperature increased from
l.Sodium a.mytol.
l03R to 106R.
4. Patient died after being in
hospital 2 hours.

1. Stiffness and spasm of jaw.
2. Left hand had 1.2,3,& 4 fingers badly
lacere. ted •
3. Right hand had several minor lacer
ations.

1. Spasticity increased.
l. Sedation.
l • .Avertin
2. Breathing became more difficult.
2. Serum therapy.
3. Temperature rose from lO lR
5 ., 000 units I.M.
to l08R.
40,000 units 1.v. 4. Heart rate increased from 144
in divided doses
to 160.
of 10 ., 000 units.
5. Patient died 10/12/33.
3. Local therapy.
Hydrogen perox ide dressings
twice daily.

I

'

I

iI ')

I �

i --------------------+---------1------------------r-

I

I

'i J'
i 1. Sedation.
1. Patient developed respiratory
Rigidity neck & jaw muscles with int
l.Magnesium sul.&:te
ability to swallow.
difficulty 11/7/33.
2. Pain lower left ohest with respira.tions 25% solution I.M. 2. Temperature increased from l00.6
R
3. Pain right shoulder.
2.Sodium lum.inal.
to 103.SR
1
2. Serum therapy.
4. Foul purulent drainage from scalp
3. Patient died 11/7/33.
15,000 units I.V.
laceration.
s. Rigid jaws and neck.
1 15,000 units I.S.
1
6. Neck drawn back towards spine.
3. Local therapy.
7. Spine not very rigid.
I.Scalp wounds
8. Extremities still flex.
cleaned with hy
drogen peroxide
irrigations.
2.Lacerations
j
dressed with moist
, hydrogen peroxide!
i dressings.
I

11.

FINISH
Term.ins. tion

'

Autopsy Findings

Laboratory Work

. 1. Death by respiratory failure. 1. Nose and throat cultures were
2. Duration in U.N.H. - 2 hours,
negative for diphtheria baoillus

I

I
I

1. Gross
1. Chronic bronchitis ..
2. A.teleotasis of lunr,s.

2. Miorosoopio
1. Bronohopneumonia.
2. Fibroma of kidney.
Brain not posted.

1. Nose and throat cultures negative for diphtheria bacillus.

No autopsy performed.

2. Duration i:c U.N.H.

- l day.

tive for diphtheria bacillus.

i

I

I
l
l

I
!

I

I

II
'

--

1. Death by respiratory failure. 1. Nose and throat cultures nega-

I

i

!
-·

I;.

I

I

1. Death by respiratory failura
2. Duration in U.N.H. - 2 days.

;
I

1. Gross
1. Tetanus.
2. Pulmonary edema..
2. Microscopic
1. Bronohopneumonia.
2. Brain - no abnormal
findings determined.

START
History and Prodromal Symptoms

Case
1.
2.
3.
4.

# 47088

Mele

Age 2
Race - whire

5.
6.

Admitted -

5/18/34

7.
8.

#

51558

Male

Age 42
-

Race

t

.,.,hi:m'

Occupation•
gardner

Ad.:nitted -

10/14/35

I

l

No history of injury.
Patient was cross and irritable 5/3/34.
Bowels and appetite were all right.
Began having choking spells and became 1
cyanotio for short periods 5/17/34.
No twitchings or generalized convulsions.
Apfetite and bowels poor - 5/16 to
5/18/34.
.
No rigidity of neok or jaw musoles able to eat.
Incubation period - 2 weeks.

1. Puncture wound of palm of left hand on l
10/4/35. No antitoxin.
2. Feeling of malaise and increased irritability 10/13/35.
3. Constriction and pain in throat muscles.
4. Inability to open mouth fully.
s. Flexion contraction of fingers of left
hand. retraction of head. and boardlike rigidity of abdomen 10/14/35.
6. Incubation period - 9 days.

I

Admission Symptoms & Physical Findix
l. Choking and irritable.
2. Unable to open mouth. Masseters seE
spastic, but imwbe voluntary.
3. Questionable neck rigidity.
4. Multiple old healed abrasions on bo�
hands, feet, and legs.
5. No spasticity.
6. No neurological findings.

••

1

2.

3.

4 ..
5.

6.

7.

B.

Neck hyperextended.
Risus sardonicus.
Claw-like deformity of left hand.
Inability to open mouth.
Neck rigidity.
Abdominal rigidity.
Puncture wound thenar eminence ot' le
hand.
Tonic state of convulsion.

BRIEF SUMMARIES OF CASES OF TETANUS TREATED
in
NEBRASKA HOSPITAL
OF
THE UlHVERSITY
KA
NEBRAS
m,'.AHA,

Admission Symptoms & Physical Findings
1. Choking and irritable.
2. Unable to open mouth. Masseters seem
spastic, but D1EW' be voluntary.
3. Questionable neck rigidity.
4. Multiple old healed abrasions on both
hands, feet, and legs.
5. No spasticity.
6. No neurological findings.

Treatment

Clinical Course

I

l

r l. Child became more restless despite
1. Sedation.
1 l.Avertin
sedation.
2. Serum therapy.
2. Some convulsions occurred.
3. Temperature increased from 100°
5,000 units I.M.
to 106 ° .
3. Local therapy.
I.Splinter found 4. Hee.rt rate increased until not
able to count.
under left big
toe. Appears to 5. Became oyanotic and died 5/21/34.
have been there
about 2 weeks.
2.Debridement
done.

..
Neck hyperextended.
Risus sardonicus.
Claw-like deformity of left hand.
Inability to open mouth.
Neek rigidity.
Abdominal rigidity.
Puneture wound thenar eminence of left
hand.
8. Tonic state of convulsion.

l.
2.
3.
4.
5.
6.
7.

l. Rigidity increased.
Sedation
I.Codeine sulfate 2. No opisthotonos.
2.Magnesiurn sul 3. Generalized convulsions.
fate 25% soluti.cn 4. Respirations became labored.
5 .. Temperature increE,sed from l00.4R
3.Cal�ium gluoo
to 104R.
nate.
6. Di.ed on 10/16/35.
4.Avertin.
5.Chloral hydrate
2. Serum therapy.
5,000 units subcu.
15,000 units I.M.
25,000 units I.V.
in 2 doses.
10,000 units I.S.
3. Local tl1erapy.
Debridement of
hand.
1.

FINISH
I

Termination

Autopsy Fir..dings

Laboratory Work

1. Death by respiratory failura 1. Urine - essentially neiative
2. Duration in U.N.R. - 3 days. 2. Blood
Hb ••••• 83%
RBC••••4.8
WBC.... 16 ,500

Autopsy not permitted.

!

Seg •••• 81
Staph •• 10

I

Young •• 2
Lymph••6
Ba.so••• ]
3. Cultures
l .lfose & throat - negative for
diphtheria bacillus.
2 .Splinter

l.Gram positive baoilU.
2.Gram positive cocci.
3.Bacillus tetanus.
3.Toe nail
Sa.me findings as from splinter.
4. Spinal fluid
Cell count - 1
1. Death by respiratory failureJ l. Urine
Color•• ••amber
2. Duration in U.N.H. - 2 days.

Sp.G ••••• 1.016
pH••••••• ao.id
Alb•••••• l+
Acetone•• positive
Micro
RBC •••••2/HPF
W"BC••••• 10-lEHPF
Casts ••• 2/LPF
Blood
2.
Hb••••••• 102%
RBC••••••4 .9
1NBC••••• .9 • 700
Seg •••••• 16
Staph •••• 41
Youngs••• 14
Plasma••• 1
Lymph •••• 21
Mono••••• 7
3. Spinal fluid
1. Cell count - 21
2. Sugar - 89mg."/,
3. Protein - 7
4. Serology - negative

t
I

II

!

i

I

l. Gross
1. Tetanus.
2. Bronohopneumonia.
2. Microsoopio
1. Foreign body in tissue.
2. Brain not posted.

START
Case

History and Prodromal Symptoms

#= 57072
Male

1. Ran fitohfork into dorsum of left hand
5/7/37.
2. No apparent treatment.
3. Symptoms developed 5/15/37. Arching of
back, convulsive seizures, stiffness of
muscles of arm, neck, back, jaw, and
difficulty in swallowing.
4. LMD gave 10,000 units I.M.
5. Incubation period - 8 days.

Age 4

Race - white
Admitted 5/16/27

#= 65102
t
Male
Age 41
Race - write
Occupationfarmer
Admitted 10/19/39

#= 76204
Male

I

1. Stepped on rusty nail which penetrated
about½ inch 10/10/39.
2. Treated at home. No antitoxin.
3. Healed well.
4. Jaws began to ~et stiff and it was hare
to swallow 10/17/39.
Neck
stiff and not ablP, to eat 10/18/3~
5.
6. LMD diagnosed tetanus and gave 2 doses
of 40,000 units of antitoxin I.V.
7. Incubation period - 7 days.

► 1.

Crushed left little finger with a crea1
can 8/25/42.
Ae;e 4
2. Received jmmediate attention&: 1500
Race - whitelt
units antitoxin.
3. Symptoms developed 9/3/42.
Admitted 4. Incubation period - 7 days.
9/3/42

BRIEF SillvlMARIES OF CASES OF TETANUS TREATED
in
THE UNIVERSITY OF NEBRASKA HOSPITAL
OMAHA, NEBRASKA

Admission Symptoms & Physical Findings
1.
2.
3.
4.

Opisthotonos.
Rigidity ma.sseter .11uscles.
Dehydrated appearance.
Small excoriation on dorsum of left
hand-noninfected site of puncture
wound.
5. Laceration of right thumb which is
pustular.
6. Numerous excor5.ations on face & body.

1. Convulsive twitchings of lower ex
tremities.
2. Rigid neck & jaw muscles.
3. Opisthotonos.

�.7.

1. Patient had several severe convul

1. Sedation
l.Morphine
2.Phenobarbita.l
3.Avertin
2. Serum therapy
20,000 units I.M.
30,000 units r.v.

si,'.)nS •

2. Adrenalin and caffeine needed for
heart & respirations.
3. Temperature increased from 100.8R
to 103R and the heart rate fro�
120 to 152 ..
4. Patient died 5/17/37.

1. Seda. tion
l.Ghloralhydrate
2.Sodhun amytol
3.Morphine
2. Serum therapy
1
l.Two doses
20,0JO units I.V.
2.0ne dose
5,ooo units I.v.
3. Local therapy
l.Continuous boric
acid packs to foot
2.Hydrogen perox
ide irrigations.
4. Nursing care
l.Da.rkened room ·
Convulsions.
2.Bed sideboards
Trismus.
3.Water & orange
Risus sardonicus.
'
juice diet by
Rigidity of neck & abdominal muscles.
nasal tube.
Opisthotonos.
4 .Fluids I.V.
Tonic spasms.
5.Spinal tap .� re
Crushed left �;i ttle finger.
moval
15cc. fluid,
r.-------

-

rt 1.
2.
3.
4.
5.

Clinical Course

Treatment

-

1. Patient sweat profusely.
2. Gradually became more restless
and convu ls ive.
3. Respirations became labored.
4. Temperature gradually climbed.
5. Patient died 10/23/39.

------------------------l.

2.
3.
4.

1. Nursin.g ca.re
l.Fluids I.V.
2.Liquid diet of 5.
1200 C /day by tub€
6.
2. Sedation
l.Avertin
�. Serum therapy
l.Single dose 50,000 units I.M.

Convulsions not prevented by avert
though deep narcosis produced.
Respiratory difficulty developed nasal oxygen given.
Heart rate 100 on entrance, increa�
to 160. Given digitalis 2cc. 2x.
Believed ventricles were dilati.!lg.
Patient a"peared deh?drated & in
acidosis. Given Hartman's solutiot
and glucose.
Breathing became irregular - Biott
type•
Patient died 9/4/42.

FINISH

-

-

Termination

1. Death by respiratory failure.

Laboratory Work
No laboratory work done.

Autopsy Findings

1. Gross.
1. Tetanus.
2. Pulmonary edema.
3. Bilateral bronohopneumonif
4. Clouding,swelling liver.
5. Clouding,swelling kidneys.
6. Slight cerebral hemorrhagi
2. Microsoopio
1. Foreign body reaction in
skin.
2. Bronchopneumonia.
3 .. Brain appeared normal.

Death by respiratory failure.

Ii.
12. Duration in U.N.H.

- 4 days.

�. Blood

1. Urine - essentially negative.

No autopsy performed.

Hb •••••88%

RBC •••• 5.02
WBC••••8,950

'

Seg •••• 47
Staph •• 8

Eosin•• 2

Lymph •• 37

Mono••• 6

-

1. Death by respiratory failure.
2. Duration in U.N.H.
1 day.

No laboratory work done.

1. Gross
1. Marked brain edema.
2. Few small areas of
pulmonary consolidation.

START
Case

# 68424
Male
Age 5
Race -white
Admitted 7/30/40

History and Prodromal Symptoms
1. Puncture wound of buttox by a rusty nail
7/22/40.
2~ Mother treated it with hot packs.
3. Developed stiff leg & limped. Was
irritablw & couldn't sleep 7/29/40.
4. Neck became spastio. Couldn't swallow
7 /30/40.

5. Couldn't sit up.
6. Abdomen was rigid.
7. Incubation period - 7 days.

# 82972
Female
Age 42
Race-white
Admitted 10/10/44

1. Sustair,ed a compound fracture of tibia &
fibula (right) with barnyard soil contrunina.tion.
2. Feeling of illness & aching jaws 10/18/4
3. Trismus 10/19/44.
4. Apparently LMD did not administer antitoxin at time of e.ccident.
5. LMD gave 60,000 units 10/19/44.
6. Incubation period - 6 days.

BRIEF SUTu1MARIES OF CASES OF TETANUS TREATED
ir:

THE UNIVERSITY OF NEBRASKA HOSPITAL
OMAHA, NEBRASKA

Admission Symptoms

&

Physical Findings

1. Neck and leg rigidity.
2. Opisthotonos.

3. Difficulty in swallowing.
4. Pain & spasm of back.

Treatment

'
Clinical
Course

1. Nursing ca.re.
l.Fluids I.V ..

1. Avertin controlled the muscle
spasm well.
2.0xygen & carbon 2. Twenty-five cc. adrenaline given
dioxide inhalatio~~
hyoodermical ly & intre.ce.rdias
2. Sedation.
for imperceptible pulse.
l.Avertin
3. Patient developed bronchopneumonia
3. Serum therapy
4. Patient died 8/2/40.
90,000 units in
divided doses I.N.
&

r.v.

4. Local therapy
Debri.dement of
wound.

!

1. Trismus.

!2.

1 3.

4..

5.
6.
7.

Opisthotonos.
Generalized muscle spasm including nee~
abdomen, and back.
Risus sardonicus.
Dyspnea.
Tachycardia.
Compound fracture right tibia & fibula.

1. Nursing care.

l. The sedation controlled the
l.Darkened room.
spasms with increasing difficulty.
2.Special nurses. 2. r.v. medication failed due to
3 .Fluids I. V.
extensive 4+ edema which de4.Transfusion - R
veloped.
500 cc. 3. Respirations becoming increasing5 .Oxygen inhal- •
ly difficult requiring freqtient
a tions.
oxyr,en inhalations, artificial
2. Sedation.
respiration, & respiratory
l.Avertin
stimulants of caffeine, metrozol
3. Serum therapy.
and coromine.
Multiple doses of 4. Patient died 10/28/44.
antitoxin I.Y. &
J.M. Total 90,000 units.
4. Local therapy.
l.Debridenent.
2.Hydrogen peroxide irrigations.
5. Additional
therapy
l.Sodium sulfadiazine.
2 .Penicillin.

FINISH
Termination
1. Death by respiratory failure.
2. Duration in U .N .H. - 4 days.

Laboratory Work
1. Blood
Hb ... u 13

RBC •••• 4.98
WBG •••• 17,400
Seg •••• 69
Staff •• 15
Young •• 2
Lymph •• 12
Mono ••• 2
2. Spinal fluid
1. Anaerobic - No growth in 24
or 72 hours.
2. Cell count - 4
3. Protein - 2

1. Death by respiratory failure.
2. Duration in U.N.H. - 8 days.

1. lTrine - essentially- negative.
2. Blood
Hb ••••• 13.7

WBC •••• 11,600

Seg •••• 54
Staff •• 24
Lymph •• 9
Mono ••• 13
10/21/44
Total serum protein - 6.59%
Blood NAN - 36.2 mg%
Serum NPN - 31.9 mg%
Albumin
- 3. 71 mg 5{
Globulin - 2.88 %
Chloride - 495 mg% as \CL
10/24/44
Co combining- power - 62.6
2
vol.%
Blood NPN - 26.7 mg%

Autopsy Findings
1. Gross
1. Tetanus.
2. Bronchopneumonia.
3. Pulmonary edema.
4. Brain
l .Flattentng of convolutions.
2.Engorged vessels.
3. Tense tura.
4.Coning of cerebellum.
2. Microscopic.
l. Bronohopneumonia.
2. Pulmonary edema.
3. Clouding swelling of
liver and kidney.

1. Gross
1. Tetanus.
2. Compound fracture.
3. Endometriosis.
4. Simplet cyst of ovaries.
f. Ateleotasis of both
lower lobes.
6. Edema of brain.
7. Fatty degeneration of
liver and kidneys.
8. Pulmonary edema.
9. Uremia.
2. Microscopic.
1. Fatty degeneration of
liver and kidneys.
2. Pulmonary atelectasis.
3. Endometriosis.
4. Tetanus.

ANALYSIS OF CASE HISTORIES OF UNIVERSITY OF NEBRASKA HOSPITAL
There have been sixteen oases of tetanus treated in
the University of Nebraska Hospital since 1932:.

Of these

sixteen cases, six patients recovered - one on whom the diagnosis
was not proven • and ten patients died.

Percentage of mortality

is 62.5%, and the percentage of recovery is 37.5%.

Twelve of

the eases have been in children.
Among the six patients who reoovered, four of them
experienced some type of serum reaction with one patient de
veloping a permanent partial paralysis.

The percentage of serum

reactions is 66 2/3%.
Autopsies were performed in seven of the ten mortality
cases.

A variation in findings is found e xcept that there might

be some signifioance to the brain postmortem.
posted in five of the seven autopsies.

The brain was

In two of these five case,

the brain appeared nonri.al; but in the other three cases, there
was marked cerebral edema.
This cerebral edema might be the result of a serum
reaction due to multiple injeotions of antitoxin.

In the two

normal oases, one case received only two injections of 15,000
units of antitoxin at essentially the same time - one intraspinal
and the other intravenously; the other case received a prophylact
dose of 10,000 units intramuscularly by the LMD and received
simultaneously on entrance to the hospital 20,000 units intra
muscularly and 30,000 units intravenously.
-62-

No repeat doses

were given.
Study of the oase histories reveals that in many in
stances there was faulty treatment of the primary lesion by
either the family or the local doctor.

These people failed to

recognize the seriousness of the situation.
The major fault in the treatment of the condition in
the University of Nebraska Hospital was the consistent use of
multiple doses of antitoxin which was unnecessary and which
expose� the patient to greater dangers of serum reactions.
It is also noticeable that sedation was by respiratory
depressants and that death occurred by respiratory failure.
These case histories further indicated the need for
a new type of treatment of tetanus - such as the one advocated and for a generalized prophylactic immunization of the people
exposec. to the dangers of the disease.
CONCLUSIONS

Tetanus is an important and ever prevalent disease.
The newer developments of this disease during the past fifteen
years �ave been reviewed in this paper.

The following points

have been emphasized.
1. A brief outline of the clinical aspect of the
disease.

2. The bacterial aspect as regards the organism and
its toxin.

3. The necessity of understanding the pathological
physiology of the disease process.
4. � contrast between the types of prophylaxis avail
able for this disease with a discussion of their limitations.
5. The care needed in the administration of antiserum.
6. The need for a universal active immunization against
the disease.
7. A discussion and criticism of the various types of
trea"::.:::ent available today.
8. A presentation of a plan tor the treatment of the
disease.
�• An analysis of the case histories of patients treated
in the University of Nebraska Hosnital.

-64-

BIBLIOGRAPHY
J.

J • .Abel

1934 Scienoe 79:.121
On Poisons and Disease and Some .Ex:periment.,
with the Toxin of the Tetanus Bacillus

J. Abel
E. Evans
B. Hampil

1936 Johns Hopkins Hosp. Bull. 59s:307
Researohes on Tetanus: Distribution
Fate of Tetanus Toxin in the Body

J. Abel

1938 Johns Hopkins Hosp. Bull. 62:91
Researches on Tetanus:; Produotion of Reflex Motor Tetanus by Intra.spinal Injections of Tetanus Toxin

B. Ham.pil
A. Jonas

w.

Chalian

and

1938 J:ohns Hopkins Hosp. Bull. 62:52a
Researohes on Tetanus: 1. Time Required
for Fixation of Fatal Concentrations of
Tetanus 2. Return Passage of Toxin via
Lymphatic Capillaries to the Cardiovascu
lar System
1938 Johns Hospkins Hosp. Bull. 62:610
Researches on Tetanus: At What Point in
the Course of Tetanus does Antitetanio
Serum Fail to Save Life

w.

J. Abel
Firor
W. Cha.lia.n

1938

Johns Hopkins Hosp. Bull. 63:373 (Dec.)
Researches on Tetanus� Further Evidence
to Show that Tetanus Toxin is not Carried
to the Central Neurons by way of the Axis
Cylinders of Motor Nerves

J. M. Albergotti

1945

South Carolina M.A. 41::55 (Mar.)
Treatment of Tetanus with Tetanus Anti
toxin and Penioillin

H. J. Bensted

1940 Lancet 2:788 (Dec.)
Immunization Against Bacterial Toxins

H. Blotner

1942 J. A. M. A. 118:219 (Jan.)
.Anaphylaotic Shock with Hemooonoentration
Treated Intravenously with Sodium Chloride
Solution

J. Boyd
J. Maclennan

1942 Lancet 2�757 (Dec.)
Tetanus in War Time

J•

-65-

J. Boyd
J. Maclennan

1942 Lancet 2�745 (Dec.)
Tetanus in the Middle East::
Active Immunization

J. Brenneman

1944 Practice of Pediatrics Vol. II, Chapt.
27�1 Edited by J. Brennema.nn
w. F. Prior Company. Hagerstown, Maryland

R. Buxton
R, Kurma.n

1945

J. K, Calvin

1941 New York State J. Med. 41:-1636 (Aug.)
Tetanus - Its Prevention and Treatment

P. Campiche

1943 West. J. Surg •• Obst., and Gynec.
51: 359 (Sept.)
The Present Status of Tetanus Prophylaxis

V.

s.

Caviness

Effect of

J. A. M. A, 127::26 (Jan,)
Report of Two Cases of Tetanus Treated
with Penicillin

1943 North Carolina M. J. 4:6 (Jan.)
Tetanus and the Essentials of Its Success
ful Treatment

C. F, Church

1945 Am. J. Dis. of Child. 69�327 (May}
Pediatric Uses of Standardized Curare

S. Cianoarelli

1940 I. Polichlinico (sez. chir.) 47:;99 (llar.)
Clinical and Therapeutical Observations
on 65 Cases of Tetanus

L. Cole

1934

Lancet 2:'475 (Sept.)
Tetanus Treated with Curare

1940

Brit. :M. J. 2:550 (Nov.)
War Medicine Series - Tetanus Therapy

1942 Brit. M. J. 2t:550 (Nov.)
War Medicine Series - Tetanus
1945

Brit. M. J • 17: 219 (Febr.)
Two Cases of Tetanus

Committee Report

1944 Am. J. of Pub. Health 34:452 (May)
Report of the Study Committee on Multiple
Antigens

R. A. Cooke
s. Hampton
w. B. Sherman
A. Stull

1940 J. A. M. A. 114:1854 (May)
Allergy Introduced by Immunization with
Tetanus Toxoid

-66-

J. V. Cooke
F. G. Jones

s. c.

c. s.

Cullen
Quinn

1943 J. A. M. A. 12hl201 (April)
The Duration of Passive Tetanus Immunity
and itfiE Effects on Aotive Immunization
with Tetanus Toxoid
1943 Surgery 14�256 (Aug.)
Use of Curare in the Treatment of Tetanus

R. Dandurand
R. Dussault

1943 J. de L':lotel-Dieu de Montreal 12:289
(Sept.)
Notes on the Treatment of Tetanus

P. F. Eastman
R. M. Nesbit

1942 J. Urol. 48�219 (Aug.)
Studies of Urinary Retention During Tetanus

s.

A. Eger

D ..

c.

J. .E. Stone
Evans

1944 Pennsylvania M. J. 47::371 (Jan.)
The Use of Hista:m.inase in Prophylactic
Tetanus Antitoxin Reactions
1943 Lancet 2�216 (Sept.)
Persistence of Antitoxin in Man Following
Active Immunization

M. Fernan-Nunez

1938 Wisconsin M. J. 37:2 (Jan.)
Tetanus Toxoid� Active Immunization against
Tetanus

P. Fildes

1927 J. Brit. E:lcper. Pathology 8�387 (Oct.)
Tetanus VI• The Conditions Under Whioh
Tetanus Spores Germinate in Vivo

W. M. Firor

1940 Aroh. Surg. 4lt299 (Aug.)
Intrathecal (Intraoisternal) Administratiot
of Antitoxin

w. M. Firor
A. Lamont
H.B. Sohumaoker
D. T. Fraser
D. L. MacLea.n
H. C. Plummer
F. o. Wishart

1940 Bull. Johns Hopkins Hosp. 67;,25 (July)
The Lethal Dose of Toxin in E:lcperimental
Tetanus

1940 .�. or Surg. 111:246 (Feb.)
Studies on the Cause of Death in Tetanus
1943 Am. J. Pub. Health 33:1107 (Sept.)
Tetanus Toxoid end Its Use for Active
Immunization

-68-

T. B. Friedman
J. A. Bigler
M. A. Werner

1942 J. Allergy 13:114 (Jan.)
Immunologic Response of Allergic Children
to Toxoid

T. B. Friedman
A. Hollander

1943

J. B. Friedman
B. Zuger
A. Hollander

1939 J. Immunol. 36:;219
Quantitative Studies on the Neutralization
of Pathogenic Agents in the Tissues by
Ciroulating Antibodies
The Permeability of Cerebral Capillaries
to Antibodies

J. R. Gallagher
C • D. Gallagher
G. G. Kaufmann

1942 New England J. Med. 227t591 (Nov.)
Tetanus Toxoid Immunization of Adolescents
Skin Reactivity, Allergy. and Unfavorable
Reactions

A. Gaxrunelgaard

J. Immunol. 47:292 (Oct.)
Studies on Tetanal Toxint The Antitoxin
Requirements of Tetanal Toxin in the Direo·
and Indirect Intraventrioular Tests

1941 Ugesk. f. la.eger 103::1370 (Oet.)
Death after a Prophylactic Injection of
Antitetanio Serum

S. M. Ghosal
L. M. Chaudhury

1942 Indian Med. Ga.z. 77:533 (Sept)
Sulfapyridine in the Treatment of Tetanus

H. R. Griffith

1945 Lancet 2:;74 (July)
Curare as an Aid to the Anesthetist

E. G. Gross
S. C. Cullen

1945 Anesthesiology 6:231 (May)
Action of Curare on the Smooth Muscle
of the Small Intestine and on the Blood
Pressure

L. Gunther
J. E. Walker

1943

A. M. Harvey

1939 J. Physiol. 96:348
The Peripheral Action of Tetanus Toxin

W. E. Herrell
D. R. Nickols
D. H. Hei Iman

1944 J. A, M. A. 125-1003 (Aug.)
Penicillin: Its Usefulness, Limitations,
Diffusion, and Detection with an Analysis
of 150 Cases

War Med. 4:;57 (July)
Localized Tetanus - Use of the Osoillograph
Electrocardiograph for Recording of Nor.:.al
and of Abnormal Action Currents of Skeletal
Muscle

-69-

s.

E. Isacson
S • A. Swenson

1941 Nebraska M. J. 26:136 (April)
Curare in Treatment of Tetanus - Case
Report

D. Jordon
J. Burrows

1942

P. N. Kartashor

1939 Vaaoh. delo. 21:509
Effeot of Tetanus Toxin Applied to
Terminal Fibers of Trigeminal Nerve in
Experimental Animals

E. Koenig

1940 Der Chirug. 12:136 (March)
Fatal Tetanus in Spite of Wound Excision
and Prophylaotio Serum. Injection

w.

L. Koerber

Textbook of Bacteriology, Edition 13 page
B. Saunders Company, Philadelphia
and London

w.

1943 J. Immun. 46�391 (June)
Evaluation of Antigenicity of Tetanus Toxoi

Maj. A. P. Long

1943 Am. J. Pub. Health 3�53 (Jan.)
Tetanus Toxoid • Its use in the United
States Army

J. H. Lyons

1944 Virginia M. Monthly 71:71 (Febr.)
Prevention of Tetanus

M. F. Mallinson

1945 Lancet 2:-75 (July)
Curare in .Anesthesia

D. M. Marv-ell
H. J. Parish

1940

Brit. M. J. 2�891 (Deo.)
Tetanus Prophylaxis and Circulating Anti
toxin in Men and Women

R. J. 'MoGill

1943 Brit. M. J. 1::40 (Jan.)
Probable Tetanus Despite Innoculation with
Toxoid - Case Report

J. J. Miller

1943 J. Pediat. 23::516 (Dec.)
Observations on Tetanus Immunization:
The Dosage of Alum Precipitated Toxoid
and the Use of Fluid Toxoid after Trauma

J. J. Miller
J. B. Humber
J. o. Dowrie

1944 J. Pediat. 24:281 (March}
Immunization with Oombined Diphtheria
and Tetanus Toxoids (Aluminum Hydroxide
Adsorbed) Containing Hemophiles Pertussis
Vaccine
-10-

J. S. Mitchell

1935 Lancet 1�262 (Febr.)
Case of Tetanus Treated with Curarine

E. Neter

1942 Proo. Soo. Exper. Biol. and Med. 51:254
(Nov.) Effect of Zephiran upon Tetanus
Toxins

E. Neter
D. Will

1942

E. Neter
D. Will

1944 J. Baot. 48:.261
Effects of Penicillin, Clave.oin, and
Streptomycin on Tetanus Toxin

C. B. Penrod

1941 M. Rec. 153:.229 (April)
Tetanus • Failure of Adequate Sulfanila
mide antitoxin Therapy - Report of a
Case

M. A. Perlstein
A. Weingla.ss

1944 Am. J. Dis. Child. 67:.360 (May)
Fatal Effects of Prolonged Complete Curariz
ation

M. M. Peshkin

1943 Am. J. Dis. Child. 65:873 (June)
Immunity to Tetanus Induced by a Third
Dose of Toxoid Two Years after Basic
Immunization

A. F. Knoll

Science 96:209 (Aug.)
Effects of Antimicrobial Substances of
Bacterial Origin upon Bacterial Toxins

1944 Am. J. Dis. Child. 67:22 (Jan.)
Immunity to Tetanus Induced by a Third
Dose 0£ Toxoid Three Years after Basic
Immunization
1945 .Am. J. Dis. Child. 69:83
Immunity to Tetanus Induced by a Third
Dose of Toxoid Four Years after Basic
Immunizati on
1934 Sohweiz. Med. Wchnsohr. 64:791 (Aug.)
Tetanus Prophylaxis and Serum Disease
K. Schauwecker

1933 Zentralbl. f. Chir. 60tl411 (June)
Serum Disease with Paralysis of Recurrent
Laryngeal Nerve after Prophylaotio In
jeotion of Tetanus Antitoxin

H. B. Schumacker 1942 Sur., Gymc., and Obst. 74:433 (Febr.)
Some Problems Concerning Active Immuniz
A. Lamont
ation against Tetanus
-71-

G. Shwartzman

1940 Proo. Soc. Exper. Biol. and Med. 44:112
(May) Association of Tetanospasm (Toxin)
with Hemoglobin in Acute Stages of
Tetanus Intoxication in Guinea Pigs

R. Spaeth

1941 Arch. Int. 'Med. 68dl33 (Dec.)
Therapy of Tetanus - Study of 275 Cases
1942 Am. J. Nursing
Tetanus

42:733 (July)

1942 Am. J. Nursing 42:1157 (Oct.)
Prophylaxis Against Tetanus
1944 Practioe of Medicine Vo� V page 25
Edited by Tice - 1923
W. F. Prior Company, Hagerstown, Maryland
H. Sprookhoff
I. Ansorge
L.

s.

Stern

1938 Deutsche Ztsohr. f. Nervenh. 147,163
Contributions to the Knowledge of Neurolog:
Affections after the Treatment with Tetanu
Serum.
1944 .Am. Rev. Soviet. Med. 1�540 (Aug.)
Direet Injection of Antiserum. into the
Cerebrospinal C anal

E. M. Taylor

1945 J. Immunol. 50:385 (June)
Production of Tetanus Toxin

H. M. Taylor

1942

C. Tenbroeok
J. Bauer

1923 J. Exper. Med. 37:479
Studies on the Relation of Teto.nus Bacillu
in the Digestive Tract to the Tetanus
Antitoxin in the Blood

H. A. Toyne
P. E. Voss

1945 M. J. Australia lt382
Penicillin in Tetanus - Three case Reports

L. Unger

1942

A. L. ·�vatkins

1942 J. A. M. A. 119s26l (May)
Electromyogra.ms in Diagnosis and Prognosis
of Tetanus

Laryngoscope 52::923 (Dec•)
Neurological Complications of Serum Sickne,
with Special Reference to the Ear

Illinois M. J. 81:139 (Febr.)
Tetanus Toxoid in the Prevention of Re
!dions in Allergic Individuals

-72-

G. Weber

1939

Deutsche Mad. Wchnschr. 65�604 (April)
Paralysis of the Plexus after Protective
Injection of Tetanus Antitoxin

H. Weloh
G. G. Soloum
R. P. Henrick

1942 J. A. M. A. 120:361 (Oot.)
Tetanus from Sulfonamide Dusting Powders
Development in Guinea Figs Treated with
Sulfa.nila.�ide Powder
1942 J. A. K. A. 119:1396
Production of Tetanus in Guinea Pigs
by Subcutaneous Implantation of Pellets
Contaminated with Spores

R. West

1936

L. A. Yeazell
C. Deamer

1943 Am. J. Dis. Child. 66:132 (Aug.)
Respons e to Stimulating Injection of
Tetanus Toxoid - Report of Study of
Children Previously Immunized with aom
bined Diphtheria and Tetanus Toxoid

B. Zuger
C .. K. Greenwald
H. Gerber

lL942.

w.

Lancet h:12 (Jan.)
Intravenous Curarine in Treatment of
Tetanus

J. Innnuno 1. 44: 309
Tetanus Immunization: Effectiveness of
the Stimulating Dose of Toxoid under
Conditions of Infection

